50 results on '"Ricardo Carnicer"'
Search Results
2. Fast, quantitative, murine cardiac 19F MRI/MRS of PFCE-labeled progenitor stem cells and macrophages at 9.4T.
- Author
-
Christakis Constantinides, Mahon Maguire, Eileen McNeill, Ricardo Carnicer, Edyta Swider, Mangala Srinivas, Carolyn A Carr, and Jurgen E Schneider
- Subjects
Medicine ,Science - Abstract
PurposeTo a) achieve cardiac 19F-Magnetic Resonance Imaging (MRI) of perfluoro-crown-ether (PFCE) labeled cardiac progenitor stem cells (CPCs) and bone-derived bone marrow macrophages, b) determine label concentration and cellular load limits, and c) achieve spectroscopic and image-based quantification.MethodsTheoretical simulations and experimental comparisons of spoiled-gradient echo (SPGR), rapid acquisition with relaxation enhancement (RARE), and steady state at free precession (SSFP) pulse sequences, and phantom validations, were conducted using 19F MRI/Magnetic Resonance Spectroscopy (MRS) at 9.4 T. Successful cell labeling was confirmed using flow cytometry and confocal microscopy. For CPC and macrophage concentration quantification, in vitro and post-mortem cardiac validations were pursued with the use of the transfection agent FuGENE. Feasibility of fast imaging is demonstrated in murine cardiac acquisitions in vivo, and in post-mortem murine skeletal and cardiac applications.ResultsSPGR/SSFP proved favorable imaging sequences yielding good signal-to-noise ratio values. Confocal microscopy confirmed heterogeneity of cellular label uptake in CPCs. 19F MRI indicated lack of additional benefits upon label concentrations above 7.5-10 mg/ml/million cells. The minimum detectable CPC load was ~500k (~10k/voxel) in two-dimensional (2D) acquisitions (3-5 min) using the butterfly coil. Additionally, absolute 19F based concentration and intensity estimates (trifluoroacetic-acid solutions, macrophages, and labeled CPCs in vitro and post-CPC injections in the post-mortem state) scaled linearly with fluorine concentrations. Fast, quantitative cardiac 19F-MRI was demonstrated with SPGR/SSFP and MRS acquisitions spanning 3-5 min, using a butterfly coil.ConclusionThe developed methodologies achieved in vivo cardiac 19F of exogenously injected labeled CPCs for the first time, accelerating imaging to a total acquisition of a few minutes, providing evidence for their potential for possible translational work. more...
- Published
- 2018
- Full Text
- View/download PDF
Catalog
3. Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling
- Author
-
Toru Hashimoto, Vidhya Sivakumaran, Ricardo Carnicer, Guangshuo Zhu, Virginia S. Hahn, Djahida Bedja, Alice Recalde, Drew Duglan, Keith M. Channon, Barbara Casadei, and David A. Kass
- Subjects
hypertrophy ,inflammation ,myocardium ,nitric oxide synthase ,oxidative stress ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundNitric oxide synthase uncoupling occurs under conditions of oxidative stress modifying the enzyme's function so it generates superoxide rather than nitric oxide. Nitric oxide synthase uncoupling occurs with chronic pressure overload, and both are ameliorated by exogenous tetrahydrobiopterin (BH4)—a cofactor required for normal nitric oxide synthase function—supporting a pathophysiological link. Genetically augmenting BH4 synthesis in endothelial cells fails to replicate this benefit, indicating that other cell types dominate the effects of exogenous BH4 administration. We tested whether the primary cellular target of BH4 is the cardiomyocyte or whether other novel mechanisms are invoked. Methods and ResultsMice with cardiomyocyte‐specific overexpression of GTP cyclohydrolase 1 (mGCH1) and wild‐type littermates underwent transverse aortic constriction. The mGCH1 mice had markedly increased myocardial BH4 and, unlike wild type, maintained nitric oxide synthase coupling after transverse aortic constriction; however, the transverse aortic constriction–induced abnormalities in cardiac morphology and function were similar in both groups. In contrast, exogenous BH4 supplementation improved transverse aortic constricted hearts in both groups, suppressed multiple inflammatory cytokines, and attenuated infiltration of inflammatory macrophages into the heart early after transverse aortic constriction. ConclusionsBH4 protection against adverse remodeling in hypertrophic cardiac disease is not driven by its prevention of myocardial nitric oxide synthase uncoupling, as presumed previously. Instead, benefits from exogenous BH4 are mediated by a protective effect coupled to suppression of inflammatory pathways and myocardial macrophage infiltration. more...
- Published
- 2016
- Full Text
- View/download PDF
4. Endothelial cell-specific roles for tetrahydrobiopterin in myocardial function, cardiac hypertrophy, and response to myocardial ischemia-reperfusion injury
- Author
-
Surawee Chuaiphichai, Sandy M. Chu, Ricardo Carnicer, Matthew Kelly, Jenifer K. Bendall, Jillian N. Simon, Gillian Douglas, Mark J. Crabtree, Barbara Casadei, and Keith M. Channon
- Subjects
Physiology ,Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
We demonstrate a critical role for endothelial cell Gch1/BH4 biosynthesis in coronary vascular function and cardiac function. Loss of cardiac endothelial cell BH4 leads to coronary vascular dysfunction, reduced functional recovery, and increased myocardial infarct size following ischemia/reperfusion injury. Targeting endothelial cell Gch1 and BH4 biosynthesis may provide a novel therapeutic target for the prevention and treatment of cardiac dysfunction, ischemia injury, and heart failure. more...
- Published
- 2023
- Full Text
- View/download PDF
5. The neuronal isoform of nitric oxide synthase (nNOS) serves as the main inducer of PKA oxidation in the heart
- Author
-
Jillian N. Simon, Nadiia Rawlings, Ajay Shah, Ricardo Carnicer, and Barbara Casadei
- Subjects
Cardiology and Cardiovascular Medicine ,Molecular Biology - Published
- 2022
- Full Text
- View/download PDF
6. Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin
- Author
-
Ricardo Carnicer, Andrea K Roalfe, Yaver Bashir, Michael Hill, Ravi DeSilva, Chandana Ratnatunga, Svetlana Reilly, Mario Petrou, Rana Sayeed, Nikhil Pal, Raja Jayaram, M. Jones, Barbara Casadei, Jillian N. Simon, Keshav Nahar, Keith M. Channon, N Goodfellow, Mark J. Crabtree, and Timothy R. Betts more...
- Subjects
Time Factors ,Refractory Period, Electrophysiological ,Physiology ,Atorvastatin ,Action Potentials ,Atrial Function, Right ,Systemic inflammation ,law.invention ,chemistry.chemical_compound ,law ,Heart Rate ,Superoxides ,Atrial Fibrillation ,AcademicSubjects/MED00200 ,Cardiopulmonary Bypass ,biology ,Atrial fibrillation ,Cardiac surgery ,Clinical trial ,Treatment Outcome ,England ,Cardiology ,cardiovascular system ,medicine.symptom ,Clinical Track Articles ,Cardiology and Cardiovascular Medicine ,Oxidation-Reduction ,medicine.drug ,Nitroso Compounds ,medicine.medical_specialty ,Biopterin ,Ischaemia-Reperfusion Injury ,Postoperative Atrial fibrillation ,Double-Blind Method ,Physiology (medical) ,Internal medicine ,Cardiopulmonary bypass ,medicine ,Humans ,Heart Atria ,Cardiac Surgical Procedures ,Atrial refractory period ,business.industry ,NADPH Oxidases ,Perioperative ,Original Articles ,medicine.disease ,Troponin ,chemistry ,biology.protein ,Nitric Oxide Synthase ,Oxidant stress ,business - Abstract
Aims Systemic inflammation and increased activity of atrial NOX2-containing NADPH oxidases have been associated with the new onset of atrial fibrillation (AF) after cardiac surgery. In addition to lowering LDL-cholesterol, statins exert rapid anti-inflammatory and antioxidant effects, the clinical significance of which remains controversial. Methods and results We first assessed the impact of cardiac surgery and cardiopulmonary bypass (CPB) on atrial nitroso-redox balance by measuring NO synthase (NOS) and GTP cyclohydrolase-1 (GCH-1) activity, biopterin content, and superoxide production in paired samples of the right atrial appendage obtained before (PRE) and after CPB and reperfusion (POST) in 116 patients. The effect of perioperative treatment with atorvastatin (80 mg once daily) on these parameters, blood biomarkers, and the post-operative atrial effective refractory period (AERP) was then evaluated in a randomized, double-blind, placebo-controlled study in 80 patients undergoing cardiac surgery on CPB. CPB and reperfusion led to a significant increase in atrial superoxide production (74% CI 71–76%, n = 46 paired samples, P, Graphical Abstract more...
- Published
- 2020
7. Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis
- Author
-
Ritu Arya, Tariq E. Khoyratty, Jade Bailey, Hector Gallart-Ayala, Mihai G. Netea, Ricardo Carnicer, André F. Rendeiro, Craig E. Wheelock, Robin P. Choudhury, Thomas Krausgruber, Irina A. Udalova, Klemen Ziberna, Alastair L. Corbin, Jurga Laurencikiene, Mark J. Crabtree, Thomas J. Cahill, Naveed Akbar, Adam Braithwaite, Joshua T. Chai, Madeleine E. Lemieux, Mikael Rydén, Laurienne Edgar, Christoph Bock, Keith M. Channon, Mohammad Alkhalil, and Niels P. Riksen more...
- Subjects
0301 basic medicine ,Mice, 129 Strain ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,Mice, Transgenic ,Inflammation ,Diabetes Mellitus, Experimental ,Mice ,03 medical and health sciences ,0302 clinical medicine ,All institutes and research themes of the Radboud University Medical Center ,Immunity ,Original Research Articles ,Physiology (medical) ,Diabetes mellitus ,Animals ,Humans ,Medicine ,Epigenetics ,glucose ,Cells, Cultured ,Endarterectomy, Carotid ,Immunity, Cellular ,epigenetics ,business.industry ,Macrophages ,Vascular damage Radboud Institute for Molecular Life Sciences [Radboudumc 16] ,Atherosclerosis ,medicine.disease ,Immunity, Innate ,030104 developmental biology ,inflammation ,Hyperglycemia ,diabetes mellitus ,Immunology ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Leukocytes, Mononuclear ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,030217 neurology & neurosurgery - Abstract
Supplemental Digital Content is available in the text., Background: Cardiovascular risk in diabetes remains elevated despite glucose-lowering therapies. We hypothesized that hyperglycemia induces trained immunity in macrophages, promoting persistent proatherogenic characteristics. Methods: Bone marrow–derived macrophages from control mice and mice with diabetes were grown in physiological glucose (5 mmol/L) and subjected to RNA sequencing (n=6), assay for transposase accessible chromatin sequencing (n=6), and chromatin immunoprecipitation sequencing (n=6) for determination of hyperglycemia-induced trained immunity. Bone marrow transplantation from mice with (n=9) or without (n=6) diabetes into (normoglycemic) Ldlr −/− mice was used to assess its functional significance in vivo. Evidence of hyperglycemia-induced trained immunity was sought in human peripheral blood mononuclear cells from patients with diabetes (n=8) compared with control subjects (n=16) and in human atherosclerotic plaque macrophages excised by laser capture microdissection. Results: In macrophages, high extracellular glucose promoted proinflammatory gene expression and proatherogenic functional characteristics through glycolysis-dependent mechanisms. Bone marrow–derived macrophages from diabetic mice retained these characteristics, even when cultured in physiological glucose, indicating hyperglycemia-induced trained immunity. Bone marrow transplantation from diabetic mice into (normoglycemic) Ldlr −/− mice increased aortic root atherosclerosis, confirming a disease-relevant and persistent form of trained innate immunity. Integrated assay for transposase accessible chromatin, chromatin immunoprecipitation, and RNA sequencing analyses of hematopoietic stem cells and bone marrow–derived macrophages revealed a proinflammatory priming effect in diabetes. The pattern of open chromatin implicated transcription factor Runt-related transcription factor 1 (Runx1). Similarly, transcriptomes of atherosclerotic plaque macrophages and peripheral leukocytes in patients with type 2 diabetes were enriched for Runx1 targets, consistent with a potential role in human disease. Pharmacological inhibition of Runx1 in vitro inhibited the trained phenotype. Conclusions: Hyperglycemia-induced trained immunity may explain why targeting elevated glucose is ineffective in reducing macrovascular risk in diabetes and suggests new targets for disease prevention and therapy. more...
- Published
- 2021
8. D Diabetes mellitus generates the substrate for atrial fibrillation by causing a localised conduction block
- Author
-
Alice Recalde, Alexandra S Mighiu, Barbara Casadei, Ricardo Carnicer, and Klemen Ziberna
- Subjects
medicine.medical_specialty ,business.industry ,Diastole ,Atrial fibrillation ,medicine.disease ,Streptozotocin ,Nerve conduction velocity ,QRS complex ,Internal medicine ,Diabetes mellitus ,Cardiology ,Medicine ,Risk factor ,PR interval ,business ,medicine.drug - Abstract
Introduction Diabetes mellitus (DM) is an important risk factor for atrial fibrillation (AF) – the most common heart rhythm disorder. However, the mechanisms underlying this association are poorly understood. In addition, patients with DM often have comorbidities, such as obesity, hypertension, dyslipidaemia, that are also independently associated with increased risk for AF. The aim of this project was to explore whether prolonged hyperglycaemia alone is sufficient to increase the risk of AF. Methods Multiple low-dose (50 mg/kg over 5 days) intraperitoneal injections of streptozotocin were used to induce DM in C57BL/6 mice. After 12 weeks of DM, left ventricular (LV) systolic and diastolic function was characterised using echocardiography. In vivo atrial electrophysiological properties and arrhythmia inducibility were assessed using transoesophageal atrial pacing. Atrial conduction time and action potential duration (APD) and conduction velocity were measured by optical mapping of isolated atria. Results Diabetic mice had significantly higher probability of in vivo AF induction (15±3% vs. 6±1%, in controls, p=0.005, n=24–26/group), atrial ECG conduction abnormalities (longer PQ interval in diabetic mice: 44±1 ms vs. 39±1 ms in controls, p=0.001, n=24–26/group), but without any changes in the P wave duration, RR, QRS or QT intervals. Diabetic mice developed modest LV diastolic dysfunction (tissue Doppler E’/A’ 1.02±0.05 vs. 1.20±0.06 in controls, p=0.04, n=11–12/group), but no LV systolic dysfunction. In addition, diabetic mice also had larger relative LA size (LA area/body weight 0.28±0.01 mm2/g vs. 0.23±0.01 mm2/g in controls, p=0.001, n=11–12/group). Optical mapping revealed a two-fold greater conduction time in diabetic left atria (LA) (39±3 ms vs. 22±2 ms in controls, p=0.0006, n=6/group), without differences in the right atrial (RA) conduction time. The APD was not significantly different in RA or LA. The regional analysis of optical mapping recordings demonstrated a significant decrease in the conduction velocity in the medial part of the RA resulting in increased conduction wavefront roughness in the LA. Finally, the medial part of the diabetic RA also had a significantly higher total collagen content (5.5±0.5 µg/mg vs. 9.1±0.6 µg/mg in controls, p=0.0002, n=9–11/group), and a decrease in the connexin 43 levels (0.92±0.05 vs. 0.66±0.4 in controls, p=0.001, n=7–8/group), with no significant changes in other parts of the atria. Conclusions Prolonged hyperglycaemia alone is sufficient to cause pathological remodelling making atria more susceptible for AF. Diabetic hearts also have modest LV diastolic dysfunction, relative LA enlargement, but no LV systolic dysfunction. In this study, we provide evidence of a novel mechanism where localized (rather than global) atrial fibrosis in a critical area causes a focal conduction defect and predisposes diabetic mice to AF. more...
- Published
- 2020
- Full Text
- View/download PDF
9. BS19 BH4 supplementation as a new treatment for diabetic cardiomyopathy
- Author
-
Keith M. Channon, Ricardo Carnicer, Barbara Casadei, Ritu Arya, and Klemen Ziberna
- Subjects
Cardiac function curve ,medicine.medical_specialty ,biology ,business.industry ,Biopterin ,medicine.disease ,Placebo ,Streptozotocin ,Nitric oxide synthase ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Internal medicine ,Diabetes mellitus ,Diabetic cardiomyopathy ,medicine ,biology.protein ,Citrulline ,business ,medicine.drug - Abstract
Background and Aims: BH4 is successfully used in the clinic for inherited BH4 deficiency and BH4-responsive phenylketonuria. In recent years, BH4 supplementation has also drawn attention as a therapy for various nitric oxide synthase (NOS)-related cardiovascular pathologies. By genetic intervention, we have been able to increase cardiac intracellular BH4 levels, modify cardiac metabolism and prevent heart dysfunction in a murine model of diabetic cardiomyopathy. The aim of this study was to assess the efficacy of an oral BH4 preparation in our animal model before translating the treatment into diabetic patients. In particular, we tested whether BH4 oral supplementation would be sufficient to increase BH4/NO levels in cardiac tissue and if this would protect the diabetic heart. Results and Methods: Diabetes was induced by streptozotocin injections over 5 consecutive days in WT mice. After 12 weeks of diabetes, mice were fed with either placebo or BH4 diet (200 mg/kg/day) for an additional 6 weeks. At the end of this period, the group of diabetic mice treated with BH4 showed a significant increase of this biopterin in the heart (9.4 ± 1.3 pmol/mg protein vs 5.8 ± 0.8 pmol/mg in non-supplemented WT. P=0.034. N=8 hearts per group), as well as an increase in the activity of NOS (0.6 ± 0.11 vs 0.2 ± 0.05 % citrulline conversion. P=0.009). WT diabetic mice showed impaired diastolic function as indicated by tissue Doppler analysis (Lower E’/A’ ratio, P Conclusion Oral BH4 was sufficient to increase the level of this biopterin and NO availability in cardiac tissue. As a result, cardiac function was preserved in a mouse model of diabetic cardiomyopathy. These results have prompted us to test the effects of BH4 on cardiac metabolism and function in diabetic patients. Conflict of interest None more...
- Published
- 2019
- Full Text
- View/download PDF
10. Improved cellular uptake of perfluorocarbon nanoparticles for in vivo murine cardiac 19F MRS/MRI and temporal tracking of progenitor cells
- Author
-
Louiza Potamiti, Ayman Al Haj Zen, Andrew M. Shaw, Eileen McNeill, Christakis Constantinides, Raquel Sainz-Urruela, Sergi Padilla-Parra, Kyriacos Kyriacou, Mangala Srinivas, Jyoti Patel, Ricardo Carnicer, Andreas Hadjisavvas, Carolyn A. Carr, Rita Alonaizan, and Edyta Swider more...
- Subjects
Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2] ,Biomedical Engineering ,Pharmaceutical Science ,Medicine (miscellaneous) ,Bioengineering ,02 engineering and technology ,Flow cytometry ,law.invention ,03 medical and health sciences ,All institutes and research themes of the Radboud University Medical Center ,Confocal microscopy ,law ,In vivo ,FuGENE ,Fluorescence microscope ,medicine ,General Materials Science ,Progenitor cell ,030304 developmental biology ,0303 health sciences ,medicine.diagnostic_test ,Chemistry ,Histology ,021001 nanoscience & nanotechnology ,In vitro ,3. Good health ,Molecular Medicine ,0210 nano-technology ,Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19] ,Biomedical engineering - Abstract
Herein, we maximize the labeling efficiency of cardiac progenitor cells (CPCs) using perfluorocarbon nanoparticles (PFCE-NP) and 19F MRI detectability, determine the temporal dynamics of single-cell label uptake, quantify the temporal viability/fluorescence persistence of labeled CPCs in vitro, and implement in vivo, murine cardiac CPC MRI/tracking that could be translatable to humans. FuGENEHD-mediated CPC PFCE-NP uptake is confirmed with flow cytometry/confocal microscopy. Epifluorescence imaging assessed temporal viability/fluorescence (up to 7 days [D]). Nonlocalized murine 19F MRS and cardiac MRI studied label localization in terminal/longitudinal tracking studies at 9.4 T (D1-D8). A 4-8 fold 19F concentration increase is evidenced in CPCs for FuGENE vs. directly labeled cells. Cardiac 19F signals post-CPC injections diminished in vivo to ~31% of their values on D1 by D7/D8. Histology confirmed CPC retention, dispersion, and macrophage-induced infiltration. Intra-cardiac injections of PFCE-NP-labeled CPCs with FuGENE can be visualized/tracked in vivo for the first time with 19F MRI. more...
- Published
- 2019
- Full Text
- View/download PDF
11. Improved cellular uptake of perfluorocarbon nanoparticles for in vivo murine cardiac
- Author
-
Christakis, Constantinides, Eileen, McNeill, Ricardo, Carnicer, Ayman, Al Haj Zen, Raquel, Sainz-Urruela, Andrew, Shaw, Jyoti, Patel, Edyta, Swider, Rita, Alonaizan, Louiza, Potamiti, Andreas, Hadjisavvas, Sergi, Padilla-Parra, Kyriacos, Kyriacou, Mangala, Srinivas, and Carolyn A, Carr more...
- Subjects
Fluorocarbons ,Time Factors ,Cell Survival ,Myocardium ,Stem Cells ,Fluorine ,Signal-To-Noise Ratio ,Magnetic Resonance Imaging ,Endocytosis ,Fluorescence ,Mice, Inbred C57BL ,Cell Tracking ,Animals ,Nanoparticles ,Female - Abstract
Herein, we maximize the labeling efficiency of cardiac progenitor cells (CPCs) using perfluorocarbon nanoparticles (PFCE-NP) and
- Published
- 2018
12. In Vivo Tracking and H-1/F-19 Magnetic Resonance Imaging of Biodegradable Polyhydroxyalkanoate/Polycaprolactone Blend Scaffolds Seeded with Labeled Cardiac Stem Cells
- Author
-
Christakis Constantinides, Pooja Basnett, Mangala Srinivas, Qasim A. Majid, Edyta Swider, Carolyn A. Carr, Barbara Lukasiewicz, Ipsita Roy, and Ricardo Carnicer
- Subjects
0301 basic medicine ,Scaffold ,Materials science ,Polyesters ,Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2] ,02 engineering and technology ,law.invention ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,All institutes and research themes of the Radboud University Medical Center ,Tissue engineering ,polycaprolactone ,In vivo ,Confocal microscopy ,law ,Animals ,General Materials Science ,Tissue Engineering ,Tissue Scaffolds ,Polymer characterization ,Polyhydroxyalkanoates ,Stem Cells ,cardiac regeneration ,technology, industry, and agriculture ,Heart ,021001 nanoscience & nanotechnology ,Magnetic Resonance Imaging ,Controlled release ,Mice, Inbred C57BL ,030104 developmental biology ,chemistry ,Polycaprolactone ,polymer scaffolds ,Polymer blend ,0210 nano-technology ,Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19] ,polymer blends ,Research Article ,cardiac progenitor stem cells ,19F magnetic resonance spectroscopy/imaging ,Biomedical engineering - Abstract
Medium-chain length polyhydroxyalkanoates (MCL-PHAs) have demonstrated exceptional properties for cardiac tissue engineering (CTE) applications. Despite prior work on MCL-PHA/polycaprolactone (PCL) blends, optimal scaffold production and use as an alternative delivery route for controlled release of seeded cardiac progenitor cells (CPCs) in CTE applications in vivo has been lacking. We present herein applicability of MCL-PHA/PCL (95/5 wt %) blends fabricated as thin films with an improved performance compared to the neat MCL-PHA. Polymer characterization confirmed the chemical structure and composition of the synthesized scaffolds, while thermal, wettability, and mechanical properties were also investigated and compared in neat and porous counterparts. In vitro cytocompatibility studies were performed using perfluorocrown-ether-nanoparticle-labeled murine CPCs and studied using confocal microscopy and 19F magnetic resonance spectroscopy and magnetic resonance imaging (MRI). Seeded scaffolds were implanted and studied in the postmortem murine heart in situ and in two additional C57BL/6 mice in vivo (using single-layered and double-layered scaffolds) and imaged immediately after and at 7 days postimplantation. Superior MCL-PHA/PCL scaffold performance has been demonstrated compared to MCL-PHA through experimental comparisons of (a) morphological data using scanning electron microscopy and (b) contact angle measurements attesting to improved CPC adhesion, (c) in vitro confocal microscopy showing increased SC proliferative capacity, and (d) mechanical testing that elicited good overall responses. In vitro MRI results justify the increased seeding density, increased in vitro MRI signal, and improved MRI visibility in vivo, in the double-layered compared to the single-layered scaffolds. Histological evaluations [bright-field, cytoplasmic (Atto647) and nuclear (4′,6-diamidino-2-phenylindole) stains] performed in conjunction with confocal microscopy imaging attest to CPC binding within the scaffold, subsequent release and migration to the neighboring myocardium, and increased retention in the murine myocardium in the case of the double-layered scaffold. Thus, MCL-PHA/PCL blends possess tremendous potential for controlled delivery of CPCs and for maximizing possible regeneration in myocardial infarction. more...
- Published
- 2018
13. 200 Nitric oxide promotes insulin-independent glucose uptake and preserves cardiac function and energetics in diabetes
- Author
-
Keith M. Channon, Klemen Ziberna, Craig A. Lygate, Simona Fortunata Mafrici, Barbara Casadei, Jillian N. Simon, Drew Duglan, and Ricardo Carnicer
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Insulin ,medicine.medical_treatment ,Glucose uptake ,Glucose transporter ,Tetrahydrobiopterin ,medicine.disease ,Nitric oxide ,Nitric oxide synthase ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Internal medicine ,Diabetic cardiomyopathy ,medicine ,biology.protein ,Glycolysis ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Introduction In the presence of diabetes (DM), myocardial glucose uptake and glycolysis are impaired and the heart rapidly adapts to use exclusively fatty acids (FA) for ATP generation. This maladaptation is believed to play a key role in the development of a cardiomyopathy over time. Here, we show that stimulating myocardial nitric oxide synthase (NOS) activity is sufficient to alleviate myocardial metabolic inflexibility, improve energy metabolism and prevent LV dysfunction in DM by increasing myocardial insulin-independent glucose transport. Methods Myocardial-specific overexpression of GTP cyclohydrolase I (mGCH1) was used to increase both tetrahydrobiopterin (BH4) and NOS activity in cardiomyocytes. Diabetes mellitus (DM) was induced by multiple low-dose streptozotocin injections (vs sham). PCr/ATP ratio was measured in perfused hearts using 31 P-MRS, glucose transport estimated by deoxy-glucose uptake, and oxygen consumption rate (OCR) of intact cardiomyocytes using a phosphorescent probe. Results As expected, sham-injected mGCH1 transgenic hearts had higher BH4 levels and constitutive NOS activity compared with WT. 12 weeks after DM induction, LV dysfunction developed in WT mice but not in mGCH1 mice, in the absence of changes in myocardial BH4 content and NOS activity in either group. WT diabetic hearts had a lower PCr/ATP ratio (1.32±0.1 vs 1.73±0.1, p Myocardial GCH1 overexpression was associated with a higher protein levels of the insulin-independent glucose transporter, GLUT-1 (p Conclusions Our study reveals that a myocardial increase in BH4 and NOS activity is sufficient to maintain a favourable substrate utilisation and preserve cardiac mitochondrial function in the presence of DM. This work provides new insight into the potential metabolic triggers of diabetic cardiomyopathy and suggests exciting new targets for BH4-based therapeutics. more...
- Published
- 2017
14. Nitric oxide synthase regulation of cardiac excitation–contraction coupling in health and disease
- Author
-
Barbara Casadei, Drew Duglan, Ricardo Carnicer, and Jillian N. Simon
- Subjects
Cardiac function curve ,medicine.medical_specialty ,Ischemia ,Pharmacology ,Nitric oxide ,chemistry.chemical_compound ,Internal medicine ,Diabetic cardiomyopathy ,medicine ,Animals ,Humans ,Protein Isoforms ,Molecular Biology ,Excitation Contraction Coupling ,Cardioprotection ,biology ,business.industry ,Myocardium ,medicine.disease ,Nitric oxide synthase ,chemistry ,Cardiovascular Diseases ,Heart failure ,biology.protein ,Cardiology ,Nitric Oxide Synthase ,Cardiology and Cardiovascular Medicine ,business ,Reperfusion injury - Abstract
Significant advances in our understanding of the ability of nitric oxide synthases (NOS) to modulate cardiac function have provided key insights into the role NOS play in the regulation of excitation–contraction (EC) coupling in health and disease. Through both cGMP-dependent and cGMP-independent (e.g. S-nitrosylation) mechanisms, NOS have the ability to alter intracellular Ca2 + handling and the myofilament response to Ca2 +, thereby impacting the systolic and diastolic performance of the myocardium. Findings from experiments using nitric oxide (NO) donors and NOS inhibition or gene deletion clearly implicate dysfunctional NOS as a critical contributor to many cardiovascular disease states. However, studies to date have only partially addressed NOS isoform-specific effects and, more importantly, how subcellular localization of NOS influences ion channels involved in myocardial EC coupling and excitability. In this review, we focus on the contribution of each NOS isoform to cardiac dysfunction and on the role of uncoupled NOS activity in common cardiac disease states, including heart failure, diabetic cardiomyopathy, ischemia/reperfusion injury and atrial fibrillation. We also review evidence that clearly indicates the importance of NO in cardioprotection. This article is part of a Special Issue entitled "Redox Signalling in the Cardiovascular System". more...
- Published
- 2014
- Full Text
- View/download PDF
15. Nitric Oxide Synthases in Heart Failure
- Author
-
Vidhya Sivakumaran, David A. Kass, Ricardo Carnicer, Barbara Casadei, and Mark J. Crabtree
- Subjects
Heart disease ,Physiology ,Clinical Biochemistry ,medicine.disease_cause ,Biochemistry ,chemistry.chemical_compound ,Superoxides ,Myocytes, Cardiac ,Cyclic GMP ,General Environmental Science ,biology ,Forum Review Articles ,Nitric oxide synthase ,Autocrine Communication ,Protein Transport ,Enzyme Induction ,Hypertension ,Disease Progression ,Signal transduction ,Signal Transduction ,medicine.medical_specialty ,Heart Diseases ,NOS1 ,Biopterin ,Nitric Oxide ,Nitric oxide ,Internal medicine ,Paracrine Communication ,Diabetes Mellitus ,medicine ,Animals ,Humans ,Calcium Signaling ,Molecular Biology ,Heart Failure ,Arginase ,Myocardium ,Cell Biology ,medicine.disease ,Protein Structure, Tertiary ,Enzyme Activation ,Endocrinology ,chemistry ,Heart failure ,biology.protein ,General Earth and Planetary Sciences ,Nitric Oxide Synthase ,Protein Processing, Post-Translational ,Neuroscience ,Oxidative stress - Abstract
Significance: The regulation of myocardial function by constitutive nitric oxide synthases (NOS) is important for the maintenance of myocardial Ca2+ homeostasis, relaxation and distensibility, and protection from arrhythmia and abnormal stress stimuli. However, sustained insults such as diabetes, hypertension, hemodynamic overload, and atrial fibrillation lead to dysfunctional NOS activity with superoxide produced instead of NO and worse pathophysiology. Recent Advances: Major strides in understanding the role of normal and abnormal constitutive NOS in the heart have revealed molecular targets by which NO modulates myocyte function and morphology, the role and nature of post-translational modifications of NOS, and factors controlling nitroso-redox balance. Localized and differential signaling from NOS1 (neuronal) versus NOS3 (endothelial) isoforms are being identified, as are methods to restore NOS function in heart disease. Critical Issues: Abnormal NOS signaling plays a key role in many cardiac disorders, while targeted modulation may potentially reverse this pathogenic source of oxidative stress. Future Directions: Improvements in the clinical translation of potent modulators of NOS function/dysfunction may ultimately provide a powerful new treatment for many hearts diseases that are fueled by nitroso-redox imbalance. Antioxid. Redox Signal. 18, 1078–1099. more...
- Published
- 2013
- Full Text
- View/download PDF
16. Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts
- Author
-
Ana Ortega, Ricardo Carnicer, Manuel Portolés, Estefanía Tarazón, Francisca Lago, Esther Roselló-Lletí, José Ramón González-Juanatey, Carolina Gil-Cayuela, and Miguel Rivera
- Subjects
Cardiomyopathy, Dilated ,Cytoplasmic Dyneins ,Male ,0301 basic medicine ,GTP' ,NOS1 ,Biopterin ,Nitric Oxide Synthase Type I ,030204 cardiovascular system & hematology ,Biology ,Article ,Nitric oxide ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Downregulation and upregulation ,Heat shock protein ,medicine ,Humans ,Sepiapterin reductase ,Multidisciplinary ,High-Throughput Nucleotide Sequencing ,Tetrahydrobiopterin ,Middle Aged ,030104 developmental biology ,chemistry ,Biochemistry ,Case-Control Studies ,Female ,Biomarkers ,medicine.drug - Abstract
An essential factor for the production of nitric oxide by nitric oxide synthase 1 (NOS1), major modulator of cardiac function, is the cofactor tetrahydrobiopterin (BH4). BH4 is regulated by GTP cyclohydrolase 1, the rate-limiting enzyme in BH4 biosynthesis which catalyses the formation of dihydroneopterin 3′triphosfate from GTP, producing BH4 after two further steps catalyzed by 6-pyruvoyltetrahydropterin synthase and sepiapterin reductase. However, there are other essential factors involved in the regulation of NOS1 activity, such as protein inhibitor of NOS1 (PIN), calmodulin, heat shock protein 90 and NOS interacting protein. All these molecules have never been analysed in human non-ischemic dilated hearts (DCM). In this study we demonstrated that the upregulation of cardiac NOS1 is not accompanied by increased NOS1 activity in DCM, partly due to the elevated PIN levels and not because of alterations in biopterin biosynthesis. Notably, the PIN concentration was significantly associated with impaired ventricular function, highlighting the importance of this NOS1 activity inhibitor in Ca2+ homeostasis. These results take a central role in the current list of targets for future studies focused on the complex cardiac dysfunction processes through more efficient harnessing of NOS1 signalling. more...
- Published
- 2016
- Full Text
- View/download PDF
17. P683The role of nitric oxide synthase (NOS) and its essential cofactor tetrahydrobiopterin (BH4) in diabetic cardiomyopathy
- Author
-
Surawee Chuaiphichai, Drew Duglan, Jillian N. Simon, Ricardo Carnicer, Barbara Casadei, Keith M. Channon, and Ashley B. Hale
- Subjects
medicine.medical_specialty ,Type 1 diabetes ,Endothelium ,biology ,Physiology ,business.industry ,Tetrahydrobiopterin ,medicine.disease ,Streptozotocin ,medicine.disease_cause ,Nitric oxide synthase ,medicine.anatomical_structure ,Endocrinology ,Physiology (medical) ,Diabetes mellitus ,Diabetic cardiomyopathy ,Internal medicine ,medicine ,biology.protein ,Cardiology and Cardiovascular Medicine ,business ,Oxidative stress ,medicine.drug - Abstract
PURPOSE: Diabetes can impact on cardiovascular health by causing a distinct condition termed "diabetic cardiomyopathy". Its characteristic left ventricular (LV) diastolic dysfunction has been associated with interstitial fibrosis, reduced NO availability, and abnormal calcium handling. However, the early triggers and the underlying cellular mechanisms remain unknown. Here, we investigate changes in vascular and myocardial reactive oxygen species (ROS) and NO availability in a murine model of type 1 diabetes, and evaluate potential beneficial effects of inducing a myocardial-specific increase in the NOS cofactor tetrahydrobiopterin (BH4) on the development of LV dysfunction. Methods: Diabetes was induced in male mice by daily intraperitoneal streptozotocin (STZ) injection (43mg/kg, 5 consecutive days). To augment myocardial BH4 and increase NOS activity, transgenic mice were generated with myocardial-specific overexpression of the rate-limiting enzyme for BH4 synthesis, GTP cyclohydrolase 1 (mGCH1 Tg). Vascular function in isolated aortas was evaluated by isometric tension studies (myograph), NOS activity and biopterins by HPLC, and superoxide production by lucigenin-enhanced chemiluminescence. High-resolution echocardiography was used to assess LV function. Results: After 12 weeks of diabetes, WT and mGCH1 Tg mice showed impaired aortic endothelium-dependent vasodilatation, in association with increased superoxide production and reduced BH4 bioavailability (n=6-10 per group). By contrast, diabetic LV homogenates showed no increase in superoxide generation or reduced BH4:BH2 ratio and no reduction in NOS activity (n=9-12 per group). Nevertheless, in vivo echocardiography revealed significant LV diastolic dysfunction in WT diabetic mice, which was prevented in mGCH1 Tg mice (E'/A' diabetic vs control: 1.52±0.08 vs 1.53±0.08 in mGCH1 Tg; 0.89±0.07 vs 1.35±0.06 in WT, n=9 per group, P more...
- Published
- 2016
18. Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man
- Author
-
Barbara Casadei, Timothy Rajakumar, Xing Liu, Svetlana Reilly, Rana Sayeed, Ulrich Schotten, George Krasopoulos, Ricardo Carnicer, Tudor A. Fulga, and Sander Verheule
- Subjects
medicine.medical_specialty ,biology ,business.industry ,NOS1 ,Management of atrial fibrillation ,Atrial fibrillation ,General Medicine ,medicine.disease ,musculoskeletal system ,Nitric oxide ,chemistry.chemical_compound ,Endocrinology ,Downregulation and upregulation ,chemistry ,Internal medicine ,medicine ,biology.protein ,cardiovascular system ,media_common.cataloged_instance ,Sinus rhythm ,European union ,Dystrophin ,business ,media_common - Abstract
Background The management of atrial fibrillation remains a challenge. This condition remodels atrial electrical properties, which promote resistance to treatment. Although remodelling has long been a therapeutic target in atrial fibrillation, its causes remain incompletely understood. We aimed to evaluate the role of miR-31-dependent reduction in dystrophin and neuronal nitric oxide synthase (nNOS, also known as NOS1) on atrial electrical properties and atrial fibrillation inducibility. Methods We recruited 258 patients (209 patients in sinus rhythm and 49 with permanent atrial fibrillation) from the John Radcliffe Hospital, Oxford, UK; written informed consent was obtained from each participant. We also used a goat model of pacing-induced atrial fibrillation (24 with atrial fibrillation vs 20 controls in normal sinus rythm) and nNos-knock-out mice (n=28 compared with 27 wild-type littermates). Gene expression of miR-31, dystrophin, and nNOS was assessed by quantitative RT-PCR; protein content was measured by immunoblotting; NOS activity was evaluated with high-performance liquid chromatography; action potential duration (APD) and rate dependent adaptation were assessed by single-cell patch-clamping, and atrial fibrillation inducibility was evaluated by transoesophageal atrial burst stimulation. Findings We found that atrial-specific upregulation of miR-31 in human atrial fibrillation caused dystrophin ( DYS ) translational repression and accelerated mRNA degradation of nNOS leading to a profound reduction in atrial DYS and nNOS protein content and in nitric oxide availability. In human atrial myocytes obtained from patients in sinus rhythm, nNOS inhibition was sufficient to recapitulate hallmark features of remodelling induced by atrial fibrillation, such as shortening of APD and loss of APD rate-dependency, but had no effect in patients with atrial fibrillation. In mice, nNos gene deletion or inhibition shortened atrial APD and increased atrial fibrillation inducibility in vivo. Inhibition of miR-31 in human atrial fibrillation recovered DYS and nNOS, and normalised APD and APD rate-dependency. Prevention of miR-31 binding to nNOS 3′UTR recovered both nNOS protein and gene expression but had no effect on the DYS protein or mRNA level (consistent with the mRNA degradation of nNOS by miR-31). Prevention of miR-31 binding to DYS 3′UTR increased DYS protein but not mRNA is consistent with translation repression of DYS by miR-31; recovery of DYS protein increased nNOS protein but not mRNA in keeping with a stabilising effect of DYS on nNOS protein. In goats, a reduction in dystrophin and nNOS protein content was associated with upregulation of miR-31 in the atria but not in the ventricles. Interpretation The findings suggest that atrial-specific upregulation of miR-31 in human atrial fibrillation is a key mechanism causing atrial loss of dystrophin and nNOS; this loss leads to the electrical phenotype induced by atrial fibrillation. Funding British Heart Foundation (BHF) Programme grant (for BC and XL), BHF Centre of Excellence in Oxford (SR), Leducq Foundation (in part for BC and SR), the European Union's seventh Framework Programme Grant Agree. more...
- Published
- 2016
19. Human ischemic cardiomyopathy shows cardiac Nos1 translocation and its increased levels are related to left ventricular performance
- Author
-
Manuel Portolés, Ana Ortega, Miguel Rivera, Francisca Lago, Ricardo Carnicer, Estefanía Tarazón, José Ramón González-Juanatey, Carolina Gil-Cayuela, and Esther Roselló-Lletí
- Subjects
0301 basic medicine ,Cardiac function curve ,Male ,medicine.medical_specialty ,NOS1 ,Myocardial Ischemia ,Nitric Oxide Synthase Type I ,030204 cardiovascular system & hematology ,Biology ,Ventricular Function, Left ,Article ,03 medical and health sciences ,0302 clinical medicine ,Sarcolemma ,Downregulation and upregulation ,Internal medicine ,medicine ,Myocyte ,Humans ,Multidisciplinary ,Ischemic cardiomyopathy ,Sequence Analysis, RNA ,Middle Aged ,Pathophysiology ,Up-Regulation ,Protein Transport ,030104 developmental biology ,Endocrinology ,Gene Expression Regulation ,Homeostasis - Abstract
The role of nitric oxide synthase 1 (NOS1) as a major modulator of cardiac function has been extensively studied in experimental models; however, its role in human ischemic cardiomyopathy (ICM) has never been analysed. Thus, the objectives of this work are to study NOS1 and NOS-related counterparts involved in regulating physiological function of myocyte, to analyze NOS1 localisation, activity, dimerisation, and its relationship with systolic function in ICM. The study has been carried out on left ventricular tissue obtained from explanted human hearts. Here we demonstrate that the upregulation of cardiac NOS1 is not accompanied by an increase in NOS activity, due in part to the alterations found in molecules involved in the regulation of its activity. We observed partial translocation of NOS1 to the sarcolemma in ischemic hearts, and a direct relationship between its protein levels and systolic ventricular function. Our findings indicate that NOS1 may be significant in the pathophysiology of human ischemic heart disease with a preservative role in maintaining myocardial homeostasis. more...
- Published
- 2016
20. Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling
- Author
-
Guangshuo Zhu, Keith M. Channon, Toru Hashimoto, Alice Recalde, Vidhya Sivakumaran, Djahida Bedja, Drew Duglan, David A. Kass, Barbara Casadei, Virginia S. Hahn, and Ricardo Carnicer
- Subjects
0301 basic medicine ,Time Factors ,Myocardial Biology ,Anti-Inflammatory Agents ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Ventricular Function, Left ,chemistry.chemical_compound ,Ventricular Dysfunction, Left ,0302 clinical medicine ,Superoxides ,oxidative stress ,Myocytes, Cardiac ,GTP Cyclohydrolase ,Original Research ,biology ,Ventricular Remodeling ,Superoxide ,nitric oxide synthase ,Tetrahydrobiopterin ,Nitric oxide synthase ,cardiovascular system ,Cytokines ,Hypertrophy, Left Ventricular ,medicine.symptom ,Inflammation Mediators ,Cardiology and Cardiovascular Medicine ,hypertrophy ,Oxidation-Reduction ,medicine.drug ,Signal Transduction ,medicine.medical_specialty ,Inflammation ,Mice, Transgenic ,Nitric Oxide ,Nitric oxide ,Proinflammatory cytokine ,03 medical and health sciences ,Internal medicine ,medicine ,myocardium ,Animals ,Humans ,Pressure overload ,Heart Failure ,business.industry ,Macrophages ,Cardiovascular Agents ,Biopterin ,Disease Models, Animal ,030104 developmental biology ,Endocrinology ,chemistry ,Cytoprotection ,inflammation ,biology.protein ,business ,Oxidant Stress ,Oxidative stress ,Basic Science Research - Abstract
Background Nitric oxide synthase uncoupling occurs under conditions of oxidative stress modifying the enzyme's function so it generates superoxide rather than nitric oxide. Nitric oxide synthase uncoupling occurs with chronic pressure overload, and both are ameliorated by exogenous tetrahydrobiopterin ( BH 4)—a cofactor required for normal nitric oxide synthase function—supporting a pathophysiological link. Genetically augmenting BH 4 synthesis in endothelial cells fails to replicate this benefit, indicating that other cell types dominate the effects of exogenous BH 4 administration. We tested whether the primary cellular target of BH 4 is the cardiomyocyte or whether other novel mechanisms are invoked. Methods and Results Mice with cardiomyocyte‐specific overexpression of GTP cyclohydrolase 1 ( mGCH 1) and wild‐type littermates underwent transverse aortic constriction. The mGCH 1 mice had markedly increased myocardial BH 4 and, unlike wild type, maintained nitric oxide synthase coupling after transverse aortic constriction; however, the transverse aortic constriction–induced abnormalities in cardiac morphology and function were similar in both groups. In contrast, exogenous BH 4 supplementation improved transverse aortic constricted hearts in both groups, suppressed multiple inflammatory cytokines, and attenuated infiltration of inflammatory macrophages into the heart early after transverse aortic constriction. Conclusions BH 4 protection against adverse remodeling in hypertrophic cardiac disease is not driven by its prevention of myocardial nitric oxide synthase uncoupling, as presumed previously. Instead, benefits from exogenous BH 4 are mediated by a protective effect coupled to suppression of inflammatory pathways and myocardial macrophage infiltration. more...
- Published
- 2016
21. Regulation of Endothelial Nitric-oxide Synthase (NOS) S-Glutathionylation by Neuronal NOS
- Author
-
M H Zhang, Svetlana Reilly, Jean-Luc Balligand, Raja Jayaram, Winifred Idigo, Yin Hua Zhang, Mark J. Crabtree, Ricardo Carnicer, and Barbara Casadei
- Subjects
inorganic chemicals ,medicine.medical_specialty ,NADPH oxidase ,biology ,Superoxide ,Nitric Oxide Synthase Type III ,Cell Biology ,Tetrahydrobiopterin ,biology.organism_classification ,Biochemistry ,Nitric oxide ,Nitric oxide synthase ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Enos ,Internal medicine ,cardiovascular system ,biology.protein ,Citrulline ,medicine ,Molecular Biology ,medicine.drug - Abstract
Myocardial constitutive No production depends on the activity of both endothelial and neuronal NOS (eNOS and nNOS, respectively). Stimulation of myocardial β(3)-adrenergic receptor (β(3)-AR) produces a negative inotropic effect that is dependent on eNOS. We evaluated whether nNOS also plays a role in β(3)-AR signaling and found that the β(3)-AR-mediated reduction in cell shortening and [Ca(2+)](i) transient amplitude was abolished both in eNOS(-/-) and nNOS(-/-) left ventricular (LV) myocytes and in wild type LV myocytes after nNOS inhibition with S-methyl-l-thiocitrulline. LV superoxide (O(2)()) production was increased in nNOS(-/-) mice and reduced by l-N(ω)-nitroarginine methyl ester (l-NAME), indicating uncoupling of eNOS activity. eNOS S-glutathionylation and Ser-1177 phosphorylation were significantly increased in nNOS(-/-) myocytes, whereas myocardial tetrahydrobiopterin, eNOS Thr-495 phosphorylation, and arginase activity did not differ between genotypes. Although inhibitors of xanthine oxidoreductase (XOR) or NOX2 NADPH oxidase caused a similar reduction in myocardial O(2)(), only XOR inhibition reduced eNOS S-glutathionylation and Ser-1177 phosphorylation and restored both eNOS coupled activity and the negative inotropic and [Ca(2+)](i) transient response to β(3)-AR stimulation in nNOS(-/-) mice. In summary, our data show that increased O(2)() production by XOR selectively uncouples eNOS activity and abolishes the negative inotropic effect of β(3)-AR stimulation in nNOS(-/-) myocytes. These findings provide unequivocal evidence of a functional interaction between the myocardial constitutive NOS isoforms and indicate that aspects of the myocardial phenotype of nNOS(-/-) mice result from disruption of eNOS signaling. more...
- Published
- 2012
- Full Text
- View/download PDF
22. Hiperhomocisteinemia. Panorama actual y contribución del ratón a su estudio
- Author
-
Mario A. Guzmán, Mario Nuño-Ayala, Natalia Guillén, María A. Navarro, Carmen Arnal, Jesús Osada, and Ricardo Carnicer
- Subjects
Pharmacology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
Resumen La homocisteina (HCY) es un aminoacido cuya elevacion sanguinea se asocia con el desarrollo de enfermedades de tipo vascular, neurologico y reproductivo. Sus niveles plasmaticos varian en funcion de la raza, el sexo, la edad y otros factores ambientales. En la presente revision se aborda su metabolismo, su fisiopatologia y las consecuencias clinicas de su elevacion. Un enfasis especial se presta al empleo del raton como modelo experimental en este campo, ya que su uso ha puesto de manifiesto la importancia de la dieta en la regulacion de la HCY. Esto, unido al desarrollo de animales modificados geneticamente con hiperhomocisteinemia, esta permitiendo una rapida caracterizacion de los mecanismos moleculares implicados en la accion in vivo de la HCY. Ademas, la combinacion de estos modelos con otros modificados geneticamente permite definir la influencia de la combinacion de factores de riesgo en el desarrollo de diversas patologias. A su vez, la exploracion en estos nuevos modelos de factores ambientales y/o farmacologicos contribuye de este modo a explicar muchas de las evidencias epidemiologicas en humanos asi como el tratamiento mas adecuado para cada condicion. more...
- Published
- 2010
- Full Text
- View/download PDF
23. Simvastatin reverses the hypertension of heterozygous mice lacking cystathionine β-synthase and apolipoprotein A-I
- Author
-
Sergio Acín, Ricardo Carnicer, Jose M. Arbones-Mainar, María A. Navarro, Natalia Guillén, Jesús Osada, and Joaquín C. Surra
- Subjects
Male ,Heterozygote ,Simvastatin ,medicine.medical_specialty ,Endothelium ,Lipoproteins ,Blotting, Western ,Cystathionine beta-Synthase ,Blood Pressure ,Nitric Oxide ,Nitric oxide ,Mice ,chemistry.chemical_compound ,Internal medicine ,medicine ,Animals ,Hypoalphalipoproteinemia ,Antihypertensive Agents ,Aorta ,Nitrites ,Pharmacology ,Nitrates ,Apolipoprotein A-I ,biology ,medicine.diagnostic_test ,Chemistry ,Paraoxonase ,nutritional and metabolic diseases ,General Medicine ,medicine.disease ,Cystathionine beta synthase ,Blood pressure ,medicine.anatomical_structure ,Endocrinology ,Hypertension ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Endothelium, Vascular ,Lipid profile ,Chromatography, Liquid ,medicine.drug - Abstract
Double heterozygous mice lacking Apoa1 and Cbs genes show mild hyperhomocysteinemia in combination with hypoalphalipoproteinemia. This situation leads to a moderate hypertension associated with a dysregulation in nitric oxide metabolism. The aim of this study was to investigate the potential beneficial effects of statin treatment in these mice. After 4 weeks of simvastatin administration, plasma parameters; apolipoproteins A-I, A-II and A-IV; lipid profile; and blood pressure were assessed, Western blotting was performed in the aorta of these mice to measure endothelial nitric oxide synthase and caveolin-1 content. The high blood pressure level present in the double heterozygous group was corrected down to that of the wild-type group after simvastatin treatment (124 ± 7.7 vs. 109 ± 11.2 mmHg, p more...
- Published
- 2008
- Full Text
- View/download PDF
24. Extra Virgin Olive Oils Increase Hepatic Fat Accumulation and Hepatic Antioxidant Protein Levels in APOE-/- Mice
- Author
-
John R. Arthur, Gary Duncan, Carmen Arnal, Garry J. Rucklidge, Karen Ross, Jesús Osada, Jose M. Arbones-Mainar, Graham W. Horgan, Baukje de Roos, María A. Navarro, Martin D. Reid, and Ricardo Carnicer more...
- Subjects
Thioredoxin-Disulfide Reductase ,Antioxidant ,Proteome ,medicine.medical_treatment ,Perilipin 2 ,Carbohydrate metabolism ,medicine.disease_cause ,Biochemistry ,Antioxidants ,Perilipin-2 ,Eating ,Mice ,chemistry.chemical_compound ,Apolipoproteins E ,Glutathione Peroxidase GPX1 ,Betaine ,Insulin resistance ,Dietary Fats, Unsaturated ,Phenols ,medicine ,Animals ,Plant Oils ,Food science ,Olive Oil ,Glutathione Transferase ,Flavonoids ,Mice, Knockout ,chemistry.chemical_classification ,Glutathione Peroxidase ,Principal Component Analysis ,biology ,Glutathione peroxidase ,Membrane Proteins ,Polyphenols ,Organ Size ,General Chemistry ,medicine.disease ,Lipids ,Liver ,chemistry ,biology.protein ,Female ,Steatosis ,Biomarkers ,Oxidative stress - Abstract
We assessed the effects of Picual and Arbequina olive oil, rich and poor in polyphenols, respectively, on plasma lipid and glucose metabolism, hepatic fat content, and the hepatic proteome in female Apoe-/- mice. Both olive oils increased hepatic fat content and adipophilin levels (p < 0.05), though Picual olive oil significantly decreased plasma triglycerides (p < 0.05). Proteomics identified a range of hepatic antioxidant enzymes that were differentially regulated by both olive oils as compared with palm oil. We found a clear association between olive oil consumption and differential regulation of adipophilin and betaine homocysteine methyl transferase as modulators of hepatic triglyceride metabolism. Therefore, our "systems biology" approach revealed hitherto unrecognized insights into the triglyceride-lowering and anti-atherogenic mechanisms of extra virgin olive oils, wherein the up-regulation of a large array of anti-oxidant enzymes may offer sufficient protection against lesion development and diminish oxidative stress levels instigated by hepatic steatosis. more...
- Published
- 2007
- Full Text
- View/download PDF
25. Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice
- Author
-
Carmen Arnal, Marcelo de las Heras, Joaquín C. Surra, Jesús Osada, Sergio Acín, Mario A. Guzmán, Francisco Blanco-Vaca, María A. Navarro, Ricardo Carnicer, and Jose M. Arbones-Mainar
- Subjects
Male ,Vitamin ,Apolipoprotein E ,medicine.medical_specialty ,Isoprostane ,Apolipoprotein B ,Homocysteine ,General Biochemistry, Genetics and Molecular Biology ,Apolipoproteins E ,Mice ,chemistry.chemical_compound ,Folic Acid ,Internal medicine ,medicine ,Animals ,General Pharmacology, Toxicology and Pharmaceutics ,Aorta ,Mice, Knockout ,biology ,Cholesterol ,business.industry ,General Medicine ,Atherosclerosis ,Lipids ,Oxidative Stress ,Apolipoproteins ,Endocrinology ,Liver ,chemistry ,Dietary Supplements ,Vitamin B Complex ,biology.protein ,lipids (amino acids, peptides, and proteins) ,business ,Lipoprotein - Abstract
Folic acid is a vitamin that when used as a dietary supplementation can improve endothelial function. To assess the effect of folic acid on the development of atherosclerosis, male apolipoprotein E-deficient mice fed a standard chow diet received either water (control group) or an aqueous solution of folic acid that provided a dose of 75 microg/kg/day, for ten weeks. At the time of sacrifice, blood was drawn and the heart removed. The study measured plasma homocysteine, lipids, lipoproteins, low-density lipoprotein (LDL) oxidation, isoprostane, paraoxonase, and apolipoproteins, and aortic atherosclerotic areas. In folic acid-treated animals, total cholesterol, mainly carried in very low-density and low-density lipoproteins, increased significantly, and homocysteine, HDL cholesterol, paraoxonase, and triglyceride levels did not change significantly. Plasma isoprostane and apolipoprotein (apo) B levels decreased. The resistance of LDL to oxidization and plasma apoA-I and apoA-IV levels increased with a concomitant decrease in the area of atherosclerotic lesions. The administration of folic acid decreased atherosclerotic lesions independently of plasma homocysteine and cholesterol levels, but was associated with plasma levels of apolipoproteins A-I, A-IV and B, and decreased oxidative stress. more...
- Published
- 2007
- Full Text
- View/download PDF
26. Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase
- Author
-
Tudor A. Fulga, Svetlana Reilly, Ricardo Carnicer, Oliver Lomas, Ulrich Schotten, Raja Jayaram, Xing Liu, Alfonso Bueno-Orovio, George Krasopoulos, Rohan S. Wijesurendra, Sander Verheule, Anna Muszkiewicz, Blanca Rodriguez, Barbara Casadei, Timothy Rajakumar, Chandana Ratnatunga, Matilde Stefanini, Maria Cristina Carena, Rana Sayeed, Nicoletta C. Surdo, Alice Recalde, Fysiologie, and RS: CARIM - R2.11 - Experimental atrial fibrillation more...
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Action Potentials ,Nitric Oxide Synthase Type I ,030204 cardiovascular system & hematology ,Article ,Dystrophin ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Downregulation and upregulation ,Internal medicine ,microRNA ,Atrial Fibrillation ,medicine ,Gene silencing ,Myocyte ,Animals ,Humans ,Myocytes, Cardiac ,Heart Atria ,Regulation of gene expression ,biology ,Goats ,Atrial fibrillation ,Arrhythmias, Cardiac ,General Medicine ,medicine.disease ,3. Good health ,Cell biology ,Up-Regulation ,mir-31 ,MicroRNAs ,030104 developmental biology ,Endocrinology ,Gene Expression Regulation ,biology.protein ,cardiovascular system - Abstract
Atrial fibrillation (AF) is a growing public health burden, and its treatment remains a challenge. AF leads to electrical remodeling of the atria, which in turn promotes AF maintenance and resistance to treatment. Although remodeling has long been a therapeutic target in AF, its causes remain poorly understood. We show that atrial-specific up-regulation of microRNA-31 (miR-31) in goat and human AF depletes neuronal nitric oxide synthase (nNOS) by accelerating mRNA decay and alters nNOS subcellular localization by repressing dystrophin translation. By shortening action potential duration and abolishing rate-dependent adaptation of the action potential duration, miR-31 overexpression and/or disruption of nNOS signaling recapitulates features of AF-induced remodeling and significantly increases AF inducibility in mice in vivo. By contrast, silencing miR-31 in atrial myocytes from patients with AF restores dystrophin and nNOS and normalizes action potential duration and its rate dependency. These findings identify atrial-specific up-regulation of miR-31 in human AF as a key mechanism causing atrial dystrophin and nNOS depletion, which in turn contributes to the atrial phenotype begetting this arrhythmia. miR-31 may therefore represent a potential therapeutic target in AF. more...
- Published
- 2015
27. Adenoviral transduction of FRET-based biosensors for cAMP in primary adult mouse cardiomyocytes
- Author
-
Oliver, Lomas, Marcella, Brescia, Ricardo, Carnicer, Stefania, Monterisi, Nicoletta C, Surdo, and Manuela, Zaccolo
- Subjects
Cardiac Imaging Techniques ,Mice ,Transduction, Genetic ,Genetic Vectors ,Cyclic AMP ,Fluorescence Resonance Energy Transfer ,Animals ,Myocytes, Cardiac ,Biosensing Techniques ,Cells, Cultured ,Adenoviridae ,Signal Transduction - Abstract
Genetically encoded biosensors that make use of fluorescence resonance energy transfer (FRET) are important tools for the study of compartmentalized cyclic nucleotide signaling in living cells. With the advent of germ line and tissue-specific transgenic technologies, the adult mouse represents a useful tool for the study of cardiovascular pathophysiology. The use of FRET-based genetically encoded biosensors coupled with this animal model represents a powerful combination for the study of cAMP signaling in live primary cardiomyocytes. In this chapter, we describe the steps required during the isolation, viral transduction, and culture of cardiomyocytes from an adult mouse to obtain reliable expression of genetically encoded FRET biosensors for the study of cAMP signaling in living cells. more...
- Published
- 2015
28. Cystathionine β-synthase is essential for female reproductive function
- Author
-
Carmen Arnal, Alfonso J. Sarría, Nobuyo Maeda, Jesús Osada, Mario A. Guzmán, Sergio Acín, Joaquín C. Surra, María A. Navarro, Pedro Muniesa, Jose M. Arbones-Mainar, and Ricardo Carnicer
- Subjects
Male ,inorganic chemicals ,Infertility ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Hyperhomocysteinemia ,Homocysteine ,media_common.quotation_subject ,Uterus ,Cystathionine beta-Synthase ,Estrous Cycle ,Ovary ,Endoplasmic Reticulum ,Mice ,chemistry.chemical_compound ,Pregnancy ,Internal medicine ,Genetics ,medicine ,Animals ,Endoplasmic Reticulum Chaperone BiP ,Molecular Biology ,Ovulation ,Heat-Shock Proteins ,Genetics (clinical) ,media_common ,Mice, Knockout ,biology ,organic chemicals ,Female infertility ,nutritional and metabolic diseases ,General Medicine ,medicine.disease ,Cystathionine beta synthase ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Endocrinology ,chemistry ,biology.protein ,Female ,Infertility, Female ,Molecular Chaperones - Abstract
In human reproduction, hyperhomocysteinemia has been reported as a risk factor for early pregnancy loss and congenital birth defects. Hyperhomocysteinemia is also recognized as a cause of maternal obstetric complications such as preeclampsia. The role of plasma hyperhomocysteinemia in female fertility was examined using cystathionine beta synthase knockout (cbs KO) mice. Cbs KO females were infertile, showed alterations in the estrus cycle and an increased progesterone response during pseudo-pregnancy induction. Both cbs KO ovaries and ovulated oocytes showed no major morphological alterations. However, placental and uterine masses were decreased at day 18 of pregnancy and showed morphological abnormalities. In cbs-KO pregnant females, the number of uterine implantation sites was not decreased despite the low number of surviving embryos. Fertility was restored when cbs-deficient ovaries were transplanted to normal ovarectomized recipients. We detected an increased uterine expression of Grp78, a marker of endoplasmic reticulum stress, which was accompanied by the decreased levels of uterine cbs mRNA in both hyperhomocysteinemic heterozygous (fertile) and homozygous (non-fertile) females. Our results indicate that cbs -/- female infertility is a consequence of the uterine failure and demonstrate that uterine endoplasmic reticulum stress and cbs expression are not determinant of infertility, suggesting that uterine dysfunction is a consequence of either hyperhomocysteinemia or other factor(s) in the uterine environment of cbs -/- animals. In summary, these studies demonstrate the potential importance of homocysteine levels for uterine handling of embryos. more...
- Published
- 2006
- Full Text
- View/download PDF
29. Hydroxytyrosol Administration Enhances Atherosclerotic Lesion Development in Apo E Deficient Mice
- Author
-
Jesús Osada, María-Isabel Covas, Valentina Ruiz-Gutiérrez, Joaquín C. Surra, María A. Navarro, Jose M. Arbones-Mainar, Ricardo Carnicer, Sergio Acín, Israel Orman, Natalia Guillén, Rafael de la Torre, Juan Fernández-Bolaños, José C. Segovia, and Alfonso J. Sarría more...
- Subjects
Male ,Apolipoprotein E ,medicine.medical_specialty ,Apolipoprotein B ,Lipoproteins ,Macrophage-1 Antigen ,Coronary Artery Disease ,Biochemistry ,Monocytes ,Lesion ,Mice ,chemistry.chemical_compound ,Apolipoproteins E ,Internal medicine ,medicine ,Animals ,Hydroxytyrosol ,Molecular Biology ,Triglycerides ,Apolipoproteins B ,DNA Primers ,Apolipoprotein A-I ,biology ,Triglyceride ,Aryldialkylphosphatase ,Reverse Transcriptase Polymerase Chain Reaction ,Cholesterol ,Monocyte ,Cholesterol, HDL ,Paraoxonase ,General Medicine ,Phenylethyl Alcohol ,Atherosclerosis ,Endocrinology ,medicine.anatomical_structure ,Transgenic animal ,chemistry ,Immunology ,biology.protein ,lipids (amino acids, peptides, and proteins) ,medicine.symptom ,Olive oil - Abstract
Hydroxytyrosol is a phenol found in olive oil. To verify the effect of hydroxytyrosol on the development of atherosclerosis, two groups of apo E deficient male mice on a standard chow diet were used: the control group receiving only water, and the second group an aqueous solution of hydroxytyrosol in order to provide a dose of 10 mg/kg/day to each mouse. This treatment was maintained for 10 weeks. At the moment of sacrifice, blood was drawn and heart removed. Plasma lipids, apolipoproteins and monocyte Mac-1 expression were assayed as well as aortic atherosclerotic areas in both groups. Data showed no significant changes in HDL cholesterol, paraoxonase, apolipoprotein B or triglyceride levels. However, hydroxytyrosol administration decreased apolipoprotein A-I and increased total cholesterol, atherosclerotic lesion areas and circulating monocytes expressing Mac-1. The latter was highly correlated with lesion areas (r = 0.65, P < 0.01). These results indicate that administration of hydroxytyrosol in low cholesterol diets increases atherosclerotic lesion associated with the degree of monocyte activation and remodelling of plasma lipoproteins. Our data supports the concept that phenolic-enriched products, out of the original matrix, could be not only non useful but also harmful. Our results suggest that the formulation of possible functional foods should approximate as much as possible the natural environment in which active molecules are found., This research was supported by grants FEGA-FEOGA (CAO99-0014), CICYT (SAF2004-08173-C03-02 and AGL2002-00495), Junta de Andalucía (CAO01-002), FISS 01/0202, Redes DGA (A-26) and FISS de investigación cooperativa C03-01 and G03-140 and by Fundación Española del Corazón., This research was supported by grants FEGA-FEOGA (CAO99-0014), CICYT (SAF2004-08173-C03-02 and AGL2002-00495), Junta de Andalucía (CAO01-002), FISS 01/0202, Redes DGA (A-26) and FISS de investigación cooperativa C03-01 and G03-140 and by Fundación Española del Corazón. R.C., S.A., M.A.N. and N.G. were recipient of DGA, FEGA-FEOGA and Fundación Cuenca Villoro fellowships. more...
- Published
- 2006
- Full Text
- View/download PDF
30. Trans-10, cis-12- and cis-9, trans-11-Conjugated Linoleic Acid Isomers Selectively Modify HDL-Apolipoprotein Composition in Apolipoprotein E Knockout Mice
- Author
-
Joaquín C. Surra, Helen M. Roche, Jesús Osada, Carmen Arnal, María A. Navarro, Ricardo Carnicer, Sergio Acín, Jose M. Arbones-Mainar, and Mario A. Guzmán
- Subjects
Male ,Apolipoprotein E ,medicine.medical_specialty ,Apolipoprotein B ,Conjugated linoleic acid ,Linoleic acid ,Apolipoprotein A-II ,Medicine (miscellaneous) ,Mice ,chemistry.chemical_compound ,Apolipoproteins E ,Isomerism ,Internal medicine ,medicine ,Animals ,Linoleic Acids, Conjugated ,Mice, Knockout ,Nutrition and Dietetics ,biology ,Aryldialkylphosphatase ,Cholesterol ,Cholesterol, HDL ,Hypertriglyceridemia ,Paraoxonase ,food and beverages ,medicine.disease ,Apolipoproteins ,Endocrinology ,Gene Expression Regulation ,Liver ,chemistry ,biology.protein ,lipids (amino acids, peptides, and proteins) - Abstract
Trans-10, cis-12-conjugated linoleic acid (CLA)-enriched diets promote atherosclerosis in mice despite increasing blood concentrations of HDL cholesterol. This suggests that under these conditions, the HDL apolipoproteins (apo) produced are abnormal. To test this hypothesis, apoE-deficient mice were fed a Western-type diet enriched with linoleic acid (control), cis-9, trans-11-CLA or trans-10, cis-12-CLA (1.0% wt/wt) for 12 wk, and the effects on HDL metabolism and apoC-III levels recorded. Compared with the control and cis-9, trans-11-CLA mice, those fed the trans-10, cis-12-CLA diet had significantly higher HDL cholesterol concentrations, and had a higher incidence of hypertriglyceridemia and hepatic steatosis. Plasma apoA-I and paraoxonase concentrations were significantly lower in the trans-10, cis-12-CLA group than in the cis-9, trans-11-CLA group. These reductions were associated with decreased hepatic expression of these proteins and a shift toward lipid-poor apolipoprotein particles. The plasma apoA-II concentration increased with its corresponding mRNA concentration in the liver, and was preferentially bound to HDL in the trans-10, cis-12-CLA mice, thus explaining the increased HDL cholesterol concentrations in this group. Significant, positive associations were found between apoA-II and C-III (r=0.883, P more...
- Published
- 2006
- Full Text
- View/download PDF
31. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation
- Author
-
Nieves González-Ramón, Joaquín C. Surra, Andrés Piñeiro, Mario A. Guzmán-García, Fermín Lampreave, María A. Navarro, María Iturralde, Sergio Acín, Jose M. Arbones-Mainar, Jesús Osada, Rakel Carpintero, Lucı́a Calleja, and Ricardo Carnicer more...
- Subjects
Male ,medicine.medical_specialty ,Apolipoprotein B ,Swine ,Turpentine ,Immunology ,Inflammation ,Apolipoprotein A-IV ,Biochemistry ,Internal medicine ,Gene cluster ,medicine ,Animals ,Immunology and Allergy ,RNA, Messenger ,Apolipoproteins C ,Molecular Biology ,Apolipoproteins A ,Triglycerides ,Apolipoprotein C-III ,Messenger RNA ,Apolipoprotein A-I ,biology ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,Interleukin ,Hematology ,Disease Models, Animal ,Cholesterol ,Endocrinology ,Gene Expression Regulation ,Liver ,Multigene Family ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Tumor necrosis factor alpha ,medicine.symptom ,Biomarkers ,Interleukin-1 - Abstract
Apolipoprotein A-IV is a member of the apo A-I/C-III/A-IV gene cluster. In order to investigate its hypothetical coordinated regulation, an acute phase was induced in pigs by turpentine oil injection. The hepatic expression of the gene cluster as well as the plasma levels of apolipoproteins were monitored at different time periods. Furthermore, the involvement of the inflammatory mediators’ interleukins 1 and 6 and tumor necrosis factor in the regulation of this gene cluster was tested in cultured pig hepatocytes, incubated with those mediators and apo A-I/C-III/A-IV gene cluster expression at the mRNA level was measured. In response to turpentine oil-induced inflammation, a decreased hepatic apo A-IV mRNA expression was observed (independent of apo A-I and apo C-III mRNA) not correlating with the plasma protein levels. The distribution of plasma apo A-IV experienced a shift from HDL to larger particles. In contrast, the changes in apo A-I and apo C-III mRNA were reflected in their corresponding plasma levels. Addition of cytokines to cultured pig hepatocytes also decreased apo A-IV and apo A-I mRNA levels. All these results show that the down-regulation of apolipoprotein A-I and A-IV messages in the liver may be mediated by interleukin 6 and TNF-a. The well-known HDL decrease found in many different acute-phase responses also appears in the pig due to the decreased expression of apolipoprotein A-I and the enlargement of the apolipoprotein A-IV-containing HDL. 2005 Elsevier Ltd. All rights reserved. more...
- Published
- 2005
- Full Text
- View/download PDF
32. Animales de experimentación utilizados como modelos en la investigación de la arteriosclerosis
- Author
-
Joaquín C. Surra, M.V. Martínez, María A. Navarro, J.M. Arbonés, Sergio Acín, Carmen Arnal, Jesús Osada, Alfonso J. Sarría, and Ricardo Carnicer
- Subjects
Pharmacology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
La presente revision aborda el metabolismo lipoproteico comparado y la induccion de la aterosclerosis con sus controversias en varios modelos animales pertenecientes a un amplio espectro evolutivo que abarca desde los roedores (raton, conejo, rata, hamster, cobaya), las aves (paloma), los cetartiodactilos (cerdo) y los carnivoros (perro) hasta los primates (macacos, Rhesus, mono verde africano). more...
- Published
- 2005
- Full Text
- View/download PDF
33. Adenoviral Transduction of FRET-Based Biosensors for cAMP in Primary Adult Mouse Cardiomyocytes
- Author
-
Ricardo Carnicer, Manuela Zaccolo, Stefania Monterisi, Marcella Brescia, Oliver Lomas, and Nicoletta C. Surdo
- Subjects
Cyclic nucleotide ,chemistry.chemical_compound ,Adenoviral transduction ,Animal model ,Förster resonance energy transfer ,chemistry ,CAMP signaling ,Transgene ,Biology ,Molecular biology ,Biosensor ,Germline ,Cell biology - Abstract
Genetically encoded biosensors that make use of fluorescence resonance energy transfer (FRET) are important tools for the study of compartmentalized cyclic nucleotide signaling in living cells. With the advent of germ line and tissue-specific transgenic technologies, the adult mouse represents a useful tool for the study of cardiovascular pathophysiology. The use of FRET-based genetically encoded biosensors coupled with this animal model represents a powerful combination for the study of cAMP signaling in live primary cardiomyocytes. In this chapter, we describe the steps required during the isolation, viral transduction, and culture of cardiomyocytes from an adult mouse to obtain reliable expression of genetically encoded FRET biosensors for the study of cAMP signaling in living cells. more...
- Published
- 2015
- Full Text
- View/download PDF
34. Abstract 17767: A MiR-31-dependent Loss of Dystrophin & Nnos in the Human Atria Plays a Key Role in Atrial Fibrillation-induced Electrical Remodelling
- Author
-
Svetlana Reilly, Xing Liu, Ricardo Carnicer, Timothy Rajakumar, Rana Sayeed, George Krasopoulos, Sander Verheule, Tudor Fulga, Ulrich Schotten, and Barbara Casadei
- Subjects
nervous system ,Physiology (medical) ,cardiovascular system ,Cardiology and Cardiovascular Medicine - Abstract
Background: Management of atrial fibrillation (AF) remains a challenge. AF remodels the atrial electrical properties, thereby increasing resistance to treatment. Although remodeling has long been a target for therapeutic intervention in AF, the mechanisms driving this phenomenon are incompletely understood. Methods & Results: Using atrial samples from 351 patients (73 AF), and 67 goats (34 AF), we show that atrial-specific upregulation of miR31 causes dystrophin (DYS) translational repression and accelerates mRNA degradation of neuronal nitric oxide synthase (nNOS) leading to a profound reduction in NO availability. Six prediction algorithms and reporter assays established DYS and nNOS as miR-31 targets. In atrial myocytes from patients with AF (hAFm), both DYS and nNOS bind to miR-31 within the RNA induced silencing complex (RISC). In actinomycin D-treated myocytes from patients in sinus rhythm (hSRm), miR31 accelerated nNOS (but not DYS) mRNA decay. mRNA of nNOS (but not DYS) & protein content of nNOS, DYS & DYS associated proteins were significantly reduced in hAFm. Inhibition of miR31 in hAFm restored both DYS & nNOS protein. Protection of the nNOS miR31 binding site with a target site blocker (TSB) restored nNOS mRNA and protein (but not DYS), whereas, DYS-TSB increased both DYS and nNOS protein (but not mRNA), in keeping with an effect of DYS restoration on nNOS protein stability. Indeed, K48-linked polyubiquitination of nNOS was increased in hAFm & prevented by proteasome inhibition with MG132. NOS: inhibition (SMTC, 100 nmol) or transfection with a miR31 mimic was employed to evaluate the impact of these findings on atrial electrical properties. Both interventions shortened action potential duration (APD90) and abolished rate-dependency of the APD90 in hSRm but not in hAFm. By contrast, miR31 inhibition restored APD & APD rate-dependency in hAFm (both reversed by SMTC) but had no effect on hSRm. In mice (n=126), nNOS gene deletion or inhibition shortened atrial APD90 & lead to a 2-fold increase in AF inducibility in response to atrial burst pacing. Conclusions: These findings identify atrial-specific upregulation of miR31 in human AF as a key mechanism causing atrial loss of dystrophin and nNOS, which, in turn, lead to the electrical phenotype begetting AF. more...
- Published
- 2014
- Full Text
- View/download PDF
35. Loss of Myocardial nNOS Mediated by Upregulation of miR-31 in Human Atria Contributes to Begetting of Atrial Fibrillation
- Author
-
Ricardo Carnicer, Oliver Lomas, Matilde Stefanini, Svetlana Reilly, Maria Cristina Carena, Alfonso Bueno-Orovio, Alice Recalde, Xing Liu, Anna Muszkiewicz, Blanca Rodriguez, Barbara Casadei, George Krasopoulos, Raja Jayaram, Rohan S. Wijesurendra, and Rana Sayeed more...
- Subjects
medicine.medical_specialty ,Messenger RNA ,Chemistry ,Biophysics ,Atrial fibrillation ,musculoskeletal system ,medicine.disease ,mir-31 ,Endocrinology ,Downregulation and upregulation ,In vivo ,Internal medicine ,cardiovascular system ,medicine ,Myocyte ,Sinus rhythm ,Patch clamp - Abstract
Rationale: Neuronal nitric oxide synthase (nNOS) expression and activity in atria are markedly reduced from patients and goats with atrial fibrillation (AF). Whether loss of nNOS contributes to AF-induced atrial electrical remodelling and its upstream mechanism remain unclear.Methodology: Whole-cell patch clamp was used to record action potentials (APs) and ion currents. N/n: number of patients or mice/ number of myocytes.Results: Inhibition of nNOS by S-methylthiocitrulline (SMTC, N/n: 12/45) induces a significant reduction in AP duration (APD) and APD rate-dependent adaptation in human right atrial myocytes with sinus rhythm (SR, N/n: 14/52). In mice, nNOS inhibition (N/n: 4/9) or nNOS-/- (N/n: 9/28) reduce APD50 and 90 by 53% and 35%, respectively.Ionic investigations show SMTC increases atrial IKur by 60%, Ito by 34% and IK1 by 27% with no change in ICa or IKr. Computer modelling shows mimicking SMTC-induced increases in IKur and IK1 successfully retrieves experimental phenotype. Furthermore blocking IKur abolishes the effect of nNOS inhibition on APD and APD rate-dependent adaptation (SMTC: N/n: 6/11 vs vehicle: N/n: 8/16). Additionally, In vivo atrial burst stimulation shows nNOS-/- mice exhibit 2 folds higher AF inducibility.In AF, upregulation of atrial specific miR-31 results in accelerating nNOS mRNA and protein decay. Inhibition of miR-31 recovers the SMTC suppressed APD90 (N/n: 3/12 in each group) and APD rate-dependent adaptation. These effects are NO-mediated as they are reversed by SMTC. Whereas in SR patients, increasing miR-31(N/n: 4/30) reduces nNOS, shortens APD and suppresses APD rate-dependent adaptation (N/n: 3/14).Conclusions: In human and mammalian atrial myocytes, a reduction in nNOS, mediating by upregulation of miR31, is an important factor retrieving key hallmarks of atrial electrical remodelling and contributing to the atrial phenotype begetting AF. more...
- Published
- 2016
- Full Text
- View/download PDF
36. Cardiomyocyte GTP cyclohydrolase 1 and tetrahydrobiopterin increase NOS1 activity and accelerate myocardial relaxation
- Author
-
Keith M. Channon, Xing Liu, Ashley B. Hale, Mark J. Crabtree, Silvia Suffredini, M H Zhang, Nicholas J. Alp, Barbara Casadei, Gregory B. Lim, Ricardo Carnicer, Svetlana Reilly, Nicoletta C. Surdo, and Jennifer K. Bendall more...
- Subjects
Cardiac function curve ,Male ,medicine.medical_specialty ,Physiology ,NOS1 ,Immunoblotting ,Biopterin ,Mice, Transgenic ,Nitric Oxide Synthase Type I ,Nitric oxide ,chemistry.chemical_compound ,Mice ,Superoxides ,Internal medicine ,medicine ,Myocyte ,Animals ,Humans ,Myocytes, Cardiac ,GTP Cyclohydrolase ,Cells, Cultured ,Calcium metabolism ,Chemistry ,Myocardium ,Heart ,Ryanodine Receptor Calcium Release Channel ,Tetrahydrobiopterin ,Phospholamban ,Enzyme Activation ,Mice, Inbred C57BL ,Sarcoplasmic Reticulum ,Endocrinology ,Mice, Inbred CBA ,Calcium ,Female ,Cardiology and Cardiovascular Medicine ,medicine.drug - Abstract
Rationale: Tetrahydrobiopterin (BH4) is an essential cofactor of nitric oxide synthases (NOS). Oral BH4 supplementation preserves cardiac function in animal models of cardiac disease; however, the mechanisms underlying these findings are not completely understood. Objective: To study the effect of myocardial transgenic overexpression of the rate-limiting enzyme in BH4 biosynthesis, GTP cyclohydrolase 1 (GCH1), on NOS activity, myocardial function, and Ca 2+ handling. Methods and Results: GCH1 overexpression significantly increased the biopterins level in left ventricular (LV) myocytes but not in the nonmyocyte component of the LV myocardium or in plasma. The ratio between BH4 and its oxidized products was lower in mGCH1-Tg, indicating that a large proportion of the myocardial biopterin pool was oxidized; nevertheless, myocardial NOS1 activity was increased in mGCH1-Tg, and superoxide release was significantly reduced. Isolated hearts and field-stimulated LV myocytes (3 Hz, 35°C) overexpressing GCH1 showed a faster relaxation and a PKA-mediated increase in the PLB Ser 16 phosphorylated fraction and in the rate of decay of the [Ca 2+ ] i transient. RyR2 S-nitrosylation and diastolic Ca 2+ leak were larger in mGCH1-Tg and I Ca density was lower; nevertheless the amplitude of the [Ca 2+ ] i transient and contraction did not differ between genotypes, because of an increase in the SR fractional release of Ca 2+ in mGCH1-Tg myocytes. Xanthine oxidoreductase inhibition abolished the difference in superoxide production but did not affect myocardial function in either group. By contrast, NOS1 inhibition abolished the differences in I Ca density, Ser 16 PLB phosphorylation, [Ca 2+ ] i decay, and myocardial relaxation between genotypes. Conclusions: Myocardial GCH1 activity and intracellular BH4 are a limiting factor for constitutive NOS1 and SERCA2A activity in the healthy myocardium. Our findings suggest that GCH1 may be a valuable target for the treatment of LV diastolic dysfunction. more...
- Published
- 2012
37. Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice
- Author
-
Mario A. Guzmán, Marisabel Mourelle, Sergio Acín, Cristina Barranquero, Carmen Arnal, Jesús Osada, Natalia Guillén, María A. Navarro, Jose M. Arbones-Mainar, Sonia Gascón, and Ricardo Carnicer
- Subjects
Apolipoprotein E ,Male ,medicine.medical_specialty ,Apolipoprotein B ,Adipose tissue ,Mice, Inbred Strains ,Isosorbide Dinitrate ,medicine.disease_cause ,Nitric Oxide ,Nitric oxide ,Lesion ,chemistry.chemical_compound ,Mice ,Apolipoproteins E ,Internal medicine ,medicine ,Animals ,Nitric Oxide Donors ,Triglycerides ,Pharmacology ,biology ,Cholesterol ,Homozygote ,General Medicine ,Atherosclerosis ,Intestines ,Endocrinology ,chemistry ,Adipose Tissue ,Liver ,biology.protein ,lipids (amino acids, peptides, and proteins) ,medicine.symptom ,Oxidative stress ,Lipoprotein - Abstract
LA419 is a novel nitric oxide-donor with antioxidant properties. The effect of this compound on the development of atherosclerosis was investigated in apolipoprotein E-deficient mice. Male mice were randomized to receive vehicle or 5 mg/kg/day LA419 for 12 weeks. At the end of this period, plasma lipid and lipoprotein parameters, oxidative stress markers and hepatic fat, and mRNA levels were measured as well as en face and cross-sectional lesion areas of the aorta. Data showed that LA419 administration reduced atherosclerotic foci and cross-sectional lesion areas by decreasing the intimae presence of macrophage-derived foam cells despite an increase in plasma cholesterol. This agent induced a significant reduction in body weight gain and mass of adipose tissue. Furthermore, compared with placebo, LA419 administration significantly reduced plasma triglycerides and apolipoprotein C-III levels as well as systemic oxidative stress, estimated by plasma 8-isoprostane. Conversely, nonesterified fatty acid and HDL cholesterol levels remained unchanged, as well as apolipoproteins A-I, A-IV, and B and paraoxonase activity. Plasma triglycerides were significantly associated with plasma levels of apolipoprotein C-III and hepatic Fsp27 mRNA expression. These results indicate that administration of LA419 modulates lesion development. These actions are partly independent of total cholesterol as well as HDL particles and related to triglyceridemia and oxidative stress. Hypotriglyceridemia is associated with an equal number of apoB-containing particles. Hence, LA419 administration could be used as a safe alternative to control the metabolic syndrome and atherosclerosis. more...
- Published
- 2008
38. Genetic background in apolipoprotein A-I and cystathionine beta-synthase deficiency
- Author
-
Carmen Arnal, Joaquín C. Surra, Rosa Morales, Jesús Osada, Ricardo Carnicer, María A. Navarro, Sergio Acín, Jose M. Arbones-Mainar, and Mario A. Guzmán
- Subjects
Male ,medicine.medical_specialty ,Hyperhomocysteinemia ,Heterozygote ,Apolipoprotein B ,Genotype ,Cystathionine beta-Synthase ,Blood Pressure ,Mice, Inbred Strains ,Nitric Oxide ,Polymerase Chain Reaction ,Nitric oxide ,chemistry.chemical_compound ,Mice ,Internal medicine ,medicine ,Animals ,Allele ,Hypoalphalipoproteinemia ,Oligonucleotide Array Sequence Analysis ,Mice, Knockout ,biology ,Apolipoprotein A-I ,Paraoxonase ,Nucleic Acid Hybridization ,Heterozygote advantage ,medicine.disease ,Cystathionine beta synthase ,Mice, Inbred C57BL ,Endocrinology ,Cholesterol ,chemistry ,Hypertension ,biology.protein ,RNA - Abstract
Double heterozygous mice lacking one allele of Cbs and Apoa1 develop hyperhomocysteinemia and hypoalphalipoproteinemia together with moderate hypertension. To study the influence of the genetic background into this specific phenotype, four groups of male mice were established: control and double heterozygous groups in C57BL/6J and in C57BL/6J x 129 backgrounds, respectively. Nitric oxide levels, systolic blood pressure, plasma lipid parameters, arylesterase activity and aorta histology were analyzed as well as oligonucleotide array hybridization of liver RNA. Results demonstrated that double heterozygous mice in C57BL/6J substrate had a milder phenotype showing lower increase in blood pressure compared to double heterozygous group in hybrid background. The severity of the phenotype in the latter group was associated with lower nitric oxide and arylesterase activity levels, and hyperplasia of the vascular media layer. Hepatic profiling of both genetic substrates showed profound differences in expression of contractile proteins that could explain these pathological findings. In summary, the phenotypic presentation of hypertension is associated with multiple processes from vascular bedside to liver as evidenced by nitric oxide production or paraoxonase levels. more...
- Published
- 2008
39. Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice
- Author
-
Joaquín C. Surra, Carmen Arnal, Valentina Ruiz-Gutiérrez, José C. Segovia, María A. Navarro, Javier S. Perona, Alfonso J. Sarría, Sergio Acín, Israel Orman, Ricardo Carnicer, Jesús Osada, Natalia Guillén, and Jose M. Arbones-Mainar more...
- Subjects
Apolipoprotein E ,Male ,Squalene ,medicine.medical_specialty ,Very low-density lipoprotein ,Isoprostane ,Apolipoprotein B ,Receptors, Cytoplasmic and Nuclear ,Biology ,Dinoprost ,Lesion ,chemistry.chemical_compound ,Mice ,ApoE-deficient mice ,Apolipoproteins E ,Internal medicine ,medicine ,Animals ,RNA, Messenger ,Lipoprotein ,Triglycerides ,Liver X Receptors ,Mice, Knockout ,Sex Characteristics ,CD11b Antigen ,Apolipoprotein A-I ,Aryldialkylphosphatase ,Body Weight ,Scavenger Receptors, Class B ,medicine.disease ,Orphan Nuclear Receptors ,Atherosclerosis ,DNA-Binding Proteins ,Fatty Liver ,Mice, Inbred C57BL ,Endocrinology ,Apolipoproteins ,Cholesterol ,chemistry ,Liver ,Receptors, LDL ,Apolipoprotein A-V ,biology.protein ,Female ,Steatosis ,medicine.symptom ,Cardiology and Cardiovascular Medicine - Abstract
BACKGROUND: Squalene is an intermediate of cholesterol biosynthesis which can be obtained from the diet where it is abundant, for example, in olive oil. The effect of this isoprenoid on the development of atherosclerosis was investigated on apoE-knockout mice. METHODS AND RESULTS: Two groups of animals, separated according to sex, were fed on standard chow diet: the control group receiving only vehicle and the second group an aqueous solution of squalene to provide a dose of 1g/kg/day in male and female mice. This treatment was maintained for 10 weeks. At the end of this period, plasma lipid parameters, oxidative stress markers and hepatic fat were measured as well as cross-sectional lesion area of aortic root in both groups. Data showed that in males squalene feeding reduced atherosclerotic lesion area independently of plasma lipids and activation of circulating monocytes. In contrast, squalene intake did not decrease lesion area in females, despite reducing plasma cholesterol and triglycerides, isoprostane and percentage of Mac-1 expressing white cells. In males, atherosclerotic lesion area was positively and significantly associated with hepatic fat content and the plasma triglycerides were also strongly associated with liver weight. CONCLUSIONS: These results indicate that administration of squalene modulates lesion development in a gender specific manner, and that accumulation of hepatic fat by liver is highly correlated with lesion progression in males. Hence, squalene administration could be used as a safe alternative to correct hepatic steatosis and atherosclerosis particularly in males. more...
- Published
- 2008
40. Genetically based hypertension generated through interaction of mild hypoalphalipoproteinemia and mild hyperhomocysteinemia
- Author
-
Joaquín C. Surra, Ricardo Carnicer, Carmen Arnal, María A. Navarro, Nobuyo Maeda, Sergio Acín, Alfonso J. Sarría, Jose M. Arbones-Mainar, Jesús Osada, and Francisco Blanco-Vaca
- Subjects
Male ,Hyperhomocysteinemia ,medicine.medical_specialty ,Heterozygote ,Homocysteine ,Apolipoprotein B ,Physiology ,chemistry.chemical_compound ,Mice ,Internal medicine ,Internal Medicine ,Medicine ,Animals ,Genetic Predisposition to Disease ,Hypoalphalipoproteinemia ,DNA Primers ,biology ,Base Sequence ,business.industry ,Cholesterol ,medicine.disease ,Cystathionine beta synthase ,Cardiac muscle hypertrophy ,Endocrinology ,chemistry ,Hypertension ,biology.protein ,Cardiology and Cardiovascular Medicine ,business ,Lipoproteins, HDL ,Lipoprotein - Abstract
BACKGROUND Hyperhomocysteinemia and hypoalphalipoproteinemia are two well-reported risk factors for cardiovascular disease. The effects of the synergistic combination of these two factors on vascular function need to be investigated. METHODS AND RESULTS Four groups of male mice were used: a control wild-type group; a group of mice heterozygous for cystathionine beta-synthase deficiency; a group of mice heterozygous for apolipoprotein A-I deficiency; and, finally, a group of double heterozygous mice, with both cystathionine beta-synthase and apolipoprotein A-I deficiency. To characterize the resulting phenotype, several parameters including plasma apolipoproteins, lipid profiles, homocysteine, blood pressure and aortic protein were analyzed. As expected, our results indicate that double heterozygous mice are a model of mild hypoalphalipoproteinemia and hyperhomocysteinemia. Further, the additive combination of both risk factors resulted in a significant increase in blood pressure compared with control animals (136 +/- 8.0 versus 126 +/- 7.5 mm Hg, P < 0.01) that was not present in single heterozygous mice. The increase in blood pressure was associated with decreased plasma nitric oxide levels, left ventricle hypertrophy and was independent of low-density lipoprotein (LDL) cholesterol, para-oxonase activity and kidney histological changes. Concomitant decreases in levels of apolipoprotein A-IV (APOA-IV) and caveolin-1 content were also found in the double heterozygous group. CONCLUSIONS Our findings suggest an additive adverse effect of hypoalphalipoproteinemia and hyperhomocysteinemia on endothelial function to generate clinical hypertension and cardiac muscle hypertrophy mediated by dysregulation in nitric oxide metabolism. more...
- Published
- 2007
41. Microarray analysis of hepatic genes differentially expressed in the presence of the unsaponifiable fraction of olive oil in apolipoprotein E-deficient mice
- Author
-
Valentina Ruiz-Gutiérrez, Javier S. Perona, María A. Navarro, Ricardo Carnicer, Natalia Guillén, Jose M. Arbones-Mainar, Jesús Osada, Joaquín C. Surra, Alfonso J. Sarría, Carmen Arnal, and Sergio Acín more...
- Subjects
Male ,Apolipoprotein E ,Apolipoprotein E-deficient mice ,Food Handling ,Medicine (miscellaneous) ,Orosomucoid ,Mice ,Apolipoproteins E ,Dietary Fats, Unsaturated ,Gene expression ,medicine ,Animals ,Plant Oils ,RNA, Messenger ,Gene ,Mice, Knockout ,Nutrition and Dietetics ,biology ,Reverse Transcriptase Polymerase Chain Reaction ,Microarray analysis techniques ,Fatty Acids ,Microarray Analysis ,medicine.disease ,Diet ,Unsaponifiable fraction ,Mice, Inbred C57BL ,Gene Expression Regulation ,Liver ,Biochemistry ,Unsaponifiable ,biology.protein ,Composition (visual arts) ,Steatosis ,Olive oil - Abstract
The hypothesis that the unsaponifiable fraction of olive oil dramatically influences hepatic gene expression was tested in mice. Two olive oils, obtained from the same olive cultivar but by different technological procedures, were characterized to show that they differed mainly in terms of the composition/quantity of this unsaponifiable fraction. Using DNA microarrays, hepatic gene expression was analysed in apoE-deficient mice fed one of two isoenergetic, isonitrogenous diets containing either 10% (w/w) olive oil or unsaponifiable fraction-enriched olive oil. To provide an initial screening of potential candidate genes involved in a differential response, only genes with remarkably modified expression (signal log2 ratio ≥3 or < -3) were further considered. The eleven genes fulfilling these prerequisites were confirmed by quantitative RT-PCR, and then analysed in apoE-deficient mice with a C57BL/6J genetic background. Orosomucoid and serum amyloid A2 were upregulated (to variable extents depending on the genetic background) in the absence of hepatic steatosis and inflammation. Fabp5 and Mt2 were also strongly upregulated. Several proteases were highly suppressed by the unsaponifiable-enriched olive diet, independent of the genetic background. The findings indicate that change in the expression of these genes is a good marker of the intake of the unsaponifiable fraction of olive oil. The results highlight the important biological effects of the unsaponifiable fraction of olive oil. The term 'monounsaturated fatty acid-enriched oil' no longer appears appropriate for describing all the oils to which it is currently applied since it does not adequately reflect that they have different biological effects. © The Authors 2007., This research was supported by grants FEGA-FEOGA (CAO99-014), Ministerio de Educación y Ciencia, CICYT (SAF2004-08 173-C03-02 and AGL2005-00 572), Junta de Andalucía (CAO01-002), FISS 01/0202, Redes FISS de investigación cooperativa C03-01 and G03-140 and by the Fundación Española del Corazón. more...
- Published
- 2007
42. Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: a role for small, dense high-density lipoproteins
- Author
-
Sergio Acín, Marino Uceda, Carmen Arnal, Joaquín C. Surra, Alfonso J. Sarría, Gabriel Beltrán, María A. Navarro, Jesús Osada, Natalia Guillén, Jose M. Arbones-Mainar, Ricardo Carnicer, Antonio José González Jiménez, Mario A. Guzmán, and María-Paz Aguilera more...
- Subjects
medicine.medical_specialty ,Very low-density lipoprotein ,Antioxidant ,Apolipoprotein B ,medicine.medical_treatment ,Biology ,Palm Oil ,Arylesterase ,chemistry.chemical_compound ,Mice ,Apolipoproteins E ,Internal medicine ,medicine ,Animals ,Plant Oils ,Food science ,Olive Oil ,Aorta ,Apolipoproteins A ,Triglyceride ,Apolipoprotein A-I ,Cholesterol ,Aryldialkylphosphatase ,Paraoxonase ,food and beverages ,Atherosclerosis ,Disease Models, Animal ,Endocrinology ,chemistry ,biology.protein ,Diet, Atherogenic ,Female ,Cardiology and Cardiovascular Medicine ,Lipoprotein - Abstract
To test the hypothesis that extra virgin olive oils from different cultivars added to Western diets might behave differently than palm oil in the development of atherosclerosis, apoE-deficient mice were fed diets containing different cultivars of olive oil for 10weeks. Female mice were assigned randomly to one of the following five groups: (1–4) fed chow diets supplemented with 0.15% (w/w) cholesterol and 20% (w/w) extra virgin olive oil from the Arbequina, Picual, Cornicabra, or Empeltre cultivars, and (5) fed a chow diet supplemented with 0.15% cholesterol and 20% palm oil. Compared to diets containing palm oil, a Western diet supplemented with one of several varieties of extra virgin olive oil decreased atherosclerosis lesions, reduced plaque size, and decreased macrophage recruitment. Unexpectedly, total plasma paraoxonase activity, apoA-I, plasma triglycerides, and cholesterol played minor roles in the regulation of differential aortic lesion development. Extra virgin olive oil induced a cholesterol-poor, apoA-IV-enriched lipoparticle that has enhanced arylesterase and antioxidant activities, which is closely associated with reductions in atherosclerotic lesions. Given the anti-atherogenic properties of extra virgin olive oil evident in animal models fed a Western diet, clinical trials are needed to establish whether these oils are a safe and effective means of treating atherosclerosis. more...
- Published
- 2006
43. Olive oil preparation determines the atherosclerotic protection in apolipoprotein E knockout mice
- Author
-
Valentina Ruiz-Gutiérrez, Carmen Arnal, José C. Segovia, Ricardo Carnicer, María A. Navarro, Javier S. Perona, Joaquín C. Surra, Jose M. Arbones-Mainar, Mario A. Guzmán, Jesús Osada, Sergio Acín, and Israel Orman more...
- Subjects
Apolipoprotein E ,Male ,Isoprostane ,Apolipoprotein B ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Fatty Acids, Nonesterified ,medicine.disease_cause ,Biochemistry ,Terpene ,Cholesterol, Dietary ,chemistry.chemical_compound ,Squalene ,Mice ,Apolipoproteins E ,medicine ,Animals ,Plant Oils ,Centrifugation ,Molecular Biology ,Olive Oil ,Triglycerides ,Mice, Knockout ,Nutrition and Dietetics ,biology ,Cholesterol ,Body Weight ,Homozygote ,Organ Size ,Atherosclerosis ,Apolipoproteins ,chemistry ,Liver ,biology.protein ,Oxidative stress ,Olive oil - Abstract
Oils enriched in monounsaturated fatty acids do not seem to behave similarly in protecting against the development of atherosclerosis in animal models, which has been attributed to the presence of soluble phenolic compounds. To test the relevance of other components of oils in the prevention of atherosclerosis, two olive oils from the same cultivar devoid of soluble phenolic compounds were prepared using different procedures (pressure or centrifugation), characterized and fed to apolipoprotein E-deficient mice as 10% (w/w) of their diet. The 2 olive oils had similar levels of monounsaturated fatty acids and squalene, but they differed in their content of linoleic, phytosterols, tocopherols, triterpenes and waxes, which were particularly enriched in the test olive oil obtained by centrifugation. In mice that received a diet enriched in the olive oil derived through centrifugation, the progression of atherosclerosis was delayed compared to the mice that received standard olive oil. That effect was associated with decreases in plasma triglycerides, total and non-high-density lipoprotein cholesterol and isoprostane 8-iso-prostaglandin F2α. Our results clearly indicate that the preparation of olive oil is crucial in determining its antiatherosclerotic effect, which extends beyond the presence of phenolic compounds. The test olive oil exerted its antiatherosclerotic effects by modifying plasma lipids and oxidative stress, and it might be a good candidate to replace other fats in functional foods., This research was supported by grants FEGA-FEOGA (CAO99-014), CICYT (SAF2004-08173-C03-02 and AGL2002-00495), Junta de Andalucía (CAO01-002), FISS 01/0202, Redes DGA (A-26) and FISS de investigación cooperativa C03-01 and G03-140 and by Fundación Española del Corazón. more...
- Published
- 2006
44. Understanding the role of dietary components on atherosclerosis using genetic engineered mouse models
- Author
-
Carmen Arnal, Jesús Osada, Joaquín C. Surra, Jose M. Arbones-Mainar, María A. Navarro, Ricardo Carnicer, Sergio Acín, Alfonso J. Sarría, Natalia Guillén, and María Victoria Martínez-Gracia
- Subjects
Alcohol Drinking ,Arteriosclerosis ,Taurine ,Iron ,Complex disease ,Ascorbic Acid ,Biology ,Arginine ,Models, Biological ,Antioxidants ,Fatty Acids, Monounsaturated ,Mice ,Apolipoproteins E ,Sex Factors ,Allergy and Immunology ,Deficient mouse ,Immunological status ,Animals ,Vitamin E ,Magnesium ,Homocysteine ,Cell Proliferation ,Genetics ,Mice, Knockout ,Models, Genetic ,Sodium ,Genetic Variation ,Phytosterols ,Genomics ,Atherosclerosis ,Dietary Fats ,Mice, Inbred C57BL ,Disease Models, Animal ,Receptors, LDL ,LDL receptor ,Fatty Acids, Unsaturated ,Insulin Resistance ,Energy Metabolism ,Genetic Engineering - Abstract
The generation by genetic engineering of two murine models to investigate atherosclerosis, such as the apoE- and LDLr- deficient mice, is providing an extraordinaire knowledge of the effect of different nutrients on this complex disease. The present revision provides a comprehensive overview of the advances in this field that point to a remarkable complexity. While some controversies over puzzling results could be explained invoking potential nutrient interactions or different food sources of nutrients, it also appears that other factors such as sex, genetic background or immunological status are emerging as generators of differential responses to nutrients during the atherosclerotic process. more...
- Published
- 2005
45. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice
- Author
-
Carmen Arnal, María A. Navarro, Ricardo Carnicer, Joaquín C. Surra, Helen M. Roche, Mario A. Guzmán, Jose M. Arbones-Mainar, Jesús Osada, and Sergio Acín
- Subjects
Apolipoprotein E ,Male ,medicine.medical_specialty ,Very low-density lipoprotein ,Conjugated linoleic acid ,Linoleic acid ,Enzyme-Linked Immunosorbent Assay ,Dinoprost ,Muscle, Smooth, Vascular ,chemistry.chemical_compound ,Mice ,Apolipoproteins E ,Isomerism ,Internal medicine ,Hyperlipidemia ,medicine ,Animals ,Linoleic Acids, Conjugated ,Aorta ,Mice, Knockout ,integumentary system ,biology ,Cholesterol ,Aryldialkylphosphatase ,Paraoxonase ,food and beverages ,Lipid metabolism ,medicine.disease ,Atherosclerosis ,Disease Models, Animal ,Oxidative Stress ,Endocrinology ,Hexosaminidases ,chemistry ,biology.protein ,Disease Progression ,Diet, Atherogenic ,lipids (amino acids, peptides, and proteins) ,Cardiology and Cardiovascular Medicine - Abstract
Research suggests that conjugated linoleic acid (CLA) may inhibit atherosclerosis, but there are contradictory results in different animal models fed heterogeneous mixtures of CLA isomers. This study addressed the hypothesis that the individual CLA isomers may exert different atherogenic properties. ApoE −/− mice were fed isocaloric, isonitrogenous westernized diets containing 0.15% cholesterol and enriched with 1% (w/w) cis -9, trans -11-CLA (c9,t11-CLA), trans -10, cis -12-CLA (t10,c12-CLA) or linoleic acid (control diet) for 12 weeks. At the end of the dietary intervention, the effects of CLA isomers on the development of atherosclerotic vascular lesions, lipid metabolism, inflammation and oxidative stress were assessed. The t10,c12-CLA diet had a profound pro-atherogenic effect, whereas c9,t11-CLA impeded the development of atherosclerosis. En face aortic lesion assessment showed more dorsal and lumbar extensions presenting atherosclerotic foci after the t10,c12-CLA diet. Furthermore, animals fed t10,c12-CLA had pronounced hyperlipidemia, higher 8- iso -prostaglandin F 2α levels, higher vulnerable atherosclerotic plaque with a lower smooth muscle and fibre contents and higher macrophage content and activation, assayed as plasma chitotriosidase compared to the control or c9,t11-CLA dietary groups. Plasma chitotriosidase activity was more closely associated with the extent of the plaque than with MOMA staining or than monocyte chemoattractant protein-1 levels. Our results demonstrate that CLA isomers differentially modulate the development of atherosclerosis, c9,t11-CLA impedes, whereas t10,c12-CLA promotes atherosclerosis. These opposing effects may be ascribed to divergent effects on lipid, oxidative, inflammatory and fibro muscular components of this pathology. Plasma chitotriosidase is a better indicator of dietary fat interventions that alter plaque monocyte activity in this murine model. more...
- Published
- 2005
46. Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice
- Author
-
Marino Uceda, María A. Navarro, Gabriel Beltrán, Jesús Osada, Jose M. Arbones-Mainar, Sergio Acín, Nobuyo Maeda, Carmen Arnal, Ricardo Carnicer, and Mario A. Guzmán
- Subjects
Apolipoprotein E ,Male ,medicine.medical_specialty ,Very low-density lipoprotein ,Mediterranean diet ,Apolipoprotein B ,Aortic Diseases ,Biology ,Diet, Mediterranean ,Cholesterol, Dietary ,chemistry.chemical_compound ,Mice ,Apolipoproteins E ,Sex Factors ,Internal medicine ,medicine ,Animals ,Plant Oils ,Drug Interactions ,RNA, Messenger ,Olive Oil ,Mice, Knockout ,Cholesterol ,Aryldialkylphosphatase ,Paraoxonase ,Atherosclerosis ,Endocrinology ,chemistry ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Female ,Cardiology and Cardiovascular Medicine ,Lipoprotein - Abstract
To test the hypothesis that cholesterol might suppress the beneficial effect of olive oil in atherosclerosis, we fed apoE KO mice diets containing extra virgin olive oil, either with or without cholesterol, for 10 weeks and assessed the development of atherosclerosis. Within each sex, mice were assigned randomly to one of the following four experimental groups: (1) a standard chow diet, (2) a chow diet supplemented with 0.1% cholesterol (w/w) cholesterol, (3) a chow diet enriched with 20% (w/w) extra virgin olive oil and (4) a chow diet containing 0.1% cholesterol and 20% extra virgin olive oil. On the standard chow diet, average plasma cholesterol levels were higher in males than in females. Olive oil- and cholesterol-enriched diets, separately or in combination, induced hypercholesterolemia in both sexes, and abolished the difference between the sexes in plasma cholesterol levels. The addition of cholesterol to chow or olive oil diets decreased apolipoprotein A-I significantly in females and serum paraoxonase activities in males. The latter activity was higher in females than in males. In both sexes, the size of aortic atherosclerotic lesions was similar in olive oil- and chow-fed animals and smaller than in cholesterol-supplemented groups. Size of aortic lesions were positively correlated with circulating paraoxonase activity, particularly in males, and the relationship remained after adjusting for apolipoprotein A-I and HDL cholesterol levels. Our results demonstrate that the nutritional regulation of paraoxonase is an important determinant of atherosclerotic lesions dependent on sex. They also suggest that the mere inclusion of olive oil in Western diets is insufficient and the adoption of Mediterranean diet would be more effective in retarding the development of atherosclerotic lesions. more...
- Published
- 2004
47. P106Loss of myocardial nNOS in human atrial fibrillation (AF) shortens action potential duration (APD) by increasing Ito: Implications for AF-induced electrical remodelling
- Author
-
Rana Sayeed, Ricardo Carnicer, R Desilva, Svetlana Reilly, George Krasopoulos, Alice Recalde, Barbara Casadei, and Xing Liu
- Subjects
medicine.medical_specialty ,Atrium (architecture) ,biology ,Physiology ,business.industry ,Atrial fibrillation ,Stimulation ,medicine.disease ,Nitric oxide synthase ,Endocrinology ,Physiology (medical) ,Internal medicine ,cardiovascular system ,biology.protein ,Medicine ,Myocyte ,Repolarization ,Sinus rhythm ,Patch clamp ,Cardiology and Cardiovascular Medicine ,business - Abstract
Purpose: Understanding the mechanism underlying atrial electrical remodelling in AF is of fundamental importance for the prevention and treatment of AF. We have recently found that neuronal nitric oxide synthase (nNOS) activity is dramatically reduced in atrial myocytes from patients with AF. Whether loss of nNOS activity contributes to AF-induced atrial electrical remodelling remains to be established. Methods: Whole-cell patch clamp was used to record action potentials (APs) and ion currents in human and murine right atrial myocytes. AF was induced in isoflurane anaesthetised mice by using trans-oesophageal electrical stimulation. N=number of patients or mice, n= number of myocytes. Results: Inhibition of nNOS by S-methylthiocitrulline (SMTC, 100 nM), induced a significant reduction in APD at 20 (38%), 50 (39%) and 90 (30%) percent of repolarization in atrial myocytes from patients in sinus rhythm (SR, N=8, n=38 control vs. N=8, n=31 in the presence SMTC, p more...
- Published
- 2014
- Full Text
- View/download PDF
48. W07.177 Hydroxityrosol administration enhances atherosclerotic lesion development in apo E deficient mice
- Author
-
I. Orman, Valentina Ruiz-Gutiérrez, Jose M. Arbones-Mainar, J. Surra, Ricardo Carnicer, Sergio Acín, María A. Navarro, J.G. Fernández-Bolaños, Carmen Arnal, Javier S. Perona, J.C. Segovia, Mario A. Guzmán-García, and Jesús Osada more...
- Subjects
Apolipoprotein E ,medicine.medical_specialty ,business.industry ,General Medicine ,Lesion ,Endocrinology ,Internal medicine ,Immunology ,Internal Medicine ,medicine ,Deficient mouse ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Published
- 2004
- Full Text
- View/download PDF
49. Extra Virgin Olive Oils Increase Hepatic Fat Accumulation and Hepatic Antioxidant Protein Levels in APOE--Mice.
- Author
-
Jose Miguel Arbones-Mainar, Karen Ross, Garry J. Rucklidge, Martin Reid, Gary Duncan, John R. Arthur, Graham W. Horgan, Maria A. Navarro, Ricardo Carnicer, Carmen Arnal, Jesus Osada, and Baukje de Roos more...
- Published
- 2007
- Full Text
- View/download PDF
50. Cloning, characterization and comparative analysis of pig plasma apolipoprotein A-IV
- Author
-
Andrés Piñeiro, Fermín Lampreave, Pedro Mata, Lucı́a Calleja, Ricardo Carnicer, Nieves González-Ramón, Jesús Osada, Clemente J. Lopez-Bote, Mario A. Guzmán-García, Beatriz Isabel, María Iturralde, Sergio Acín, and María A. Navarro more...
- Subjects
DNA, Complementary ,Apolipoprotein B ,Swine ,Molecular Sequence Data ,Sequence alignment ,Biology ,Apolipoprotein A-IV ,Complementary DNA ,Genetics ,Animals ,Amino Acid Sequence ,Cloning, Molecular ,Peptide sequence ,Apolipoproteins A ,Phylogeny ,chemistry.chemical_classification ,Base Sequence ,Sequence Homology, Amino Acid ,General Medicine ,Glutamic acid ,Sequence Analysis, DNA ,Molecular biology ,Amino acid ,Glutamine ,chemistry ,Biochemistry ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Hydrophobic and Hydrophilic Interactions ,Sequence Alignment - Abstract
Pig apolipoprotein (apo) A-IV cDNA was cloned, characterized and compared to the human ortholog. Mature porcine apo A-IV consists of 362 amino acids and displays a 75.6% sequence identity with human protein. Pig apo A-IV is the smallest reported mammalian apo A-IV because it lacks the repeated motifs of glutamine and glutamic acid at the carboxyl terminus. A phylogenic tree of apo A-IV mammalian proteins reveals that porcine apo A-IV is more closely related to humans and primates than to rodents. This protein is highly hydrophobic and is mainly associated with lipoproteins. more...
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.